Gene Symbol | Gene ID | Gene Info |
---|---|---|
Runx2
|
ENSMUSG00000039153.10 | runt related transcription factor 2 |
Bcl11a
|
ENSMUSG00000000861.9 | B cell CLL/lymphoma 11A (zinc finger protein) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_24091481_24092040 | Bcl11a | 11090 | 0.140762 | -0.59 | 7.1e-07 | Click! |
chr11_24136488_24136778 | Bcl11a | 5746 | 0.167478 | 0.57 | 2.5e-06 | Click! |
chr11_24136032_24136417 | Bcl11a | 6155 | 0.165019 | 0.56 | 3.6e-06 | Click! |
chr11_24135447_24135695 | Bcl11a | 6808 | 0.161812 | 0.50 | 4.2e-05 | Click! |
chr11_24094125_24094421 | Bcl11a | 13603 | 0.137034 | -0.50 | 4.8e-05 | Click! |
chr17_44736465_44736621 | Runx2 | 105 | 0.907372 | -0.37 | 4.0e-03 | Click! |
chr17_44735779_44736411 | Runx2 | 81 | 0.729058 | -0.35 | 5.8e-03 | Click! |
chr17_44731048_44731199 | Runx2 | 3570 | 0.206573 | -0.34 | 8.8e-03 | Click! |
chr17_44806867_44807018 | Runx2 | 7284 | 0.208763 | -0.32 | 1.4e-02 | Click! |
chr17_44809638_44809789 | Runx2 | 4513 | 0.233215 | -0.28 | 2.9e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_28620746_28622145 | 26.26 |
Gfi1b |
growth factor independent 1B |
500 |
0.68 |
chr16_92824962_92826063 | 25.22 |
Runx1 |
runt related transcription factor 1 |
266 |
0.94 |
chr7_100465236_100467118 | 24.75 |
C2cd3 |
C2 calcium-dependent domain containing 3 |
770 |
0.37 |
chr17_84180639_84182724 | 24.12 |
Gm36279 |
predicted gene, 36279 |
4075 |
0.18 |
chr4_46854379_46855929 | 23.76 |
Gabbr2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
4748 |
0.3 |
chr19_5842574_5845856 | 20.19 |
Neat1 |
nuclear paraspeckle assembly transcript 1 (non-protein coding) |
1044 |
0.25 |
chr6_86078066_86079298 | 19.19 |
Add2 |
adducin 2 (beta) |
598 |
0.65 |
chr5_135041733_135042807 | 18.72 |
Stx1a |
syntaxin 1A (brain) |
1004 |
0.3 |
chr9_107489458_107490875 | 18.62 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
15438 |
0.08 |
chr17_48300015_48301474 | 18.21 |
Treml2 |
triggering receptor expressed on myeloid cells-like 2 |
358 |
0.8 |
chr2_127369985_127371247 | 17.63 |
Adra2b |
adrenergic receptor, alpha 2b |
7330 |
0.15 |
chr5_74064229_74066220 | 17.08 |
Usp46 |
ubiquitin specific peptidase 46 |
524 |
0.65 |
chr1_125676834_125678312 | 17.02 |
Gpr39 |
G protein-coupled receptor 39 |
578 |
0.8 |
chr8_120292266_120293650 | 16.68 |
Gse1 |
genetic suppressor element 1, coiled-coil protein |
64502 |
0.09 |
chr11_87756102_87757558 | 15.55 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chr9_107975554_107976970 | 15.40 |
Uba7 |
ubiquitin-like modifier activating enzyme 7 |
46 |
0.91 |
chr18_75384437_75388058 | 15.29 |
Smad7 |
SMAD family member 7 |
11333 |
0.21 |
chr6_120819964_120820819 | 15.09 |
Atp6v1e1 |
ATPase, H+ transporting, lysosomal V1 subunit E1 |
1992 |
0.25 |
chr11_83065104_83067047 | 14.55 |
Slfn2 |
schlafen 2 |
963 |
0.31 |
chrX_150547515_150548479 | 14.28 |
Alas2 |
aminolevulinic acid synthase 2, erythroid |
538 |
0.44 |
chr7_133700764_133701966 | 14.18 |
Uros |
uroporphyrinogen III synthase |
1173 |
0.35 |
chr8_25542987_25545804 | 13.48 |
Gm16159 |
predicted gene 16159 |
9165 |
0.11 |
chr7_100854551_100855928 | 13.39 |
Relt |
RELT tumor necrosis factor receptor |
190 |
0.92 |
chr3_102165384_102165916 | 13.31 |
Vangl1 |
VANGL planar cell polarity 1 |
290 |
0.87 |
chr4_46400544_46400900 | 13.05 |
Hemgn |
hemogen |
3514 |
0.16 |
chr6_125071043_125072167 | 12.46 |
Lpar5 |
lysophosphatidic acid receptor 5 |
328 |
0.72 |
chr7_100492685_100494805 | 12.40 |
Ucp2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
50 |
0.95 |
chr15_97361270_97362062 | 12.37 |
Pced1b |
PC-esterase domain containing 1B |
449 |
0.88 |
chr14_32167230_32167769 | 12.35 |
Ncoa4 |
nuclear receptor coactivator 4 |
1378 |
0.28 |
chr3_116860395_116860804 | 12.34 |
Frrs1 |
ferric-chelate reductase 1 |
1032 |
0.41 |
chr8_94985246_94986199 | 12.31 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
154 |
0.93 |
chr7_99594627_99596228 | 12.04 |
Arrb1 |
arrestin, beta 1 |
804 |
0.48 |
chr2_115858978_115861125 | 12.00 |
Meis2 |
Meis homeobox 2 |
8816 |
0.31 |
chr14_75176818_75177839 | 11.97 |
Lcp1 |
lymphocyte cytosolic protein 1 |
1120 |
0.45 |
chr17_36869615_36870619 | 11.87 |
Trim10 |
tripartite motif-containing 10 |
543 |
0.55 |
chr8_122536554_122537967 | 11.46 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
14069 |
0.09 |
chr19_53194082_53195694 | 11.38 |
Add3 |
adducin 3 (gamma) |
65 |
0.97 |
chr5_64810297_64813272 | 11.25 |
Klf3 |
Kruppel-like factor 3 (basic) |
555 |
0.71 |
chr4_104876046_104876409 | 11.16 |
C8a |
complement component 8, alpha polypeptide |
156 |
0.96 |
chr14_48538424_48539155 | 11.14 |
4930572G02Rik |
RIKEN cDNA 4930572G02 gene |
430 |
0.76 |
chr9_83253415_83254213 | 11.14 |
Gm27216 |
predicted gene 27216 |
208 |
0.95 |
chr6_90333325_90334527 | 11.11 |
Uroc1 |
urocanase domain containing 1 |
637 |
0.57 |
chr14_79298239_79299672 | 11.04 |
Rgcc |
regulator of cell cycle |
2690 |
0.24 |
chr6_31125380_31126701 | 11.03 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr11_75449209_75449924 | 11.01 |
Wdr81 |
WD repeat domain 81 |
214 |
0.84 |
chr10_80856664_80858456 | 10.94 |
Sppl2b |
signal peptide peptidase like 2B |
439 |
0.61 |
chr16_95456632_95459094 | 10.94 |
Erg |
ETS transcription factor |
1382 |
0.55 |
chr8_105300988_105301570 | 10.89 |
E2f4 |
E2F transcription factor 4 |
2646 |
0.08 |
chr4_46040988_46042013 | 10.87 |
Tmod1 |
tropomodulin 1 |
2291 |
0.3 |
chr6_83068298_83071797 | 10.74 |
Tlx2 |
T cell leukemia, homeobox 2 |
178 |
0.81 |
chr2_158142922_158143689 | 10.68 |
Tgm2 |
transglutaminase 2, C polypeptide |
3061 |
0.21 |
chr5_125056018_125058841 | 10.65 |
Gm42838 |
predicted gene 42838 |
412 |
0.71 |
chr10_81497570_81499812 | 10.60 |
S1pr4 |
sphingosine-1-phosphate receptor 4 |
1441 |
0.16 |
chr1_172501767_172503923 | 10.58 |
Tagln2 |
transgelin 2 |
1593 |
0.22 |
chr11_97434598_97436859 | 10.57 |
Arhgap23 |
Rho GTPase activating protein 23 |
557 |
0.73 |
chr12_91745342_91746056 | 10.56 |
Ston2 |
stonin 2 |
385 |
0.85 |
chr12_13180713_13181236 | 10.46 |
Gm24208 |
predicted gene, 24208 |
17211 |
0.16 |
chr16_91804661_91805209 | 10.35 |
Itsn1 |
intersectin 1 (SH3 domain protein 1A) |
299 |
0.9 |
chr15_73176794_73178055 | 10.30 |
Ago2 |
argonaute RISC catalytic subunit 2 |
423 |
0.85 |
chr17_48449646_48450503 | 10.26 |
Tspo2 |
translocator protein 2 |
1 |
0.96 |
chr6_143832506_143833713 | 10.20 |
Sox5 |
SRY (sex determining region Y)-box 5 |
113979 |
0.06 |
chr11_20635291_20636677 | 10.19 |
Sertad2 |
SERTA domain containing 2 |
4005 |
0.26 |
chr9_74865733_74868961 | 10.16 |
Onecut1 |
one cut domain, family member 1 |
863 |
0.54 |
chr5_137569837_137570642 | 10.15 |
Tfr2 |
transferrin receptor 2 |
370 |
0.67 |
chr5_74062697_74063380 | 10.11 |
Usp46 |
ubiquitin specific peptidase 46 |
2710 |
0.15 |
chr5_90492212_90493160 | 10.10 |
Afp |
alpha fetoprotein |
1448 |
0.33 |
chr16_18429039_18430122 | 10.10 |
Txnrd2 |
thioredoxin reductase 2 |
655 |
0.54 |
chr7_132773129_132773862 | 10.07 |
Fam53b |
family with sequence similarity 53, member B |
3421 |
0.25 |
chr1_71100990_71101619 | 10.04 |
Bard1 |
BRCA1 associated RING domain 1 |
1842 |
0.43 |
chr11_7197824_7198759 | 10.03 |
Igfbp1 |
insulin-like growth factor binding protein 1 |
509 |
0.77 |
chr4_57914999_57916744 | 10.02 |
D630039A03Rik |
RIKEN cDNA D630039A03 gene |
426 |
0.84 |
chr19_55938446_55939225 | 10.00 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
40526 |
0.17 |
chr11_102373109_102373996 | 9.93 |
Bloodlinc |
Bloodlinc, erythroid developmental long intergenic non-protein coding transcript |
3468 |
0.12 |
chr2_32081622_32082932 | 9.88 |
Fam78a |
family with sequence similarity 78, member A |
1506 |
0.26 |
chr7_25131634_25132945 | 9.87 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
188 |
0.91 |
chr18_60500054_60500289 | 9.86 |
Smim3 |
small integral membrane protein 3 |
1405 |
0.38 |
chr5_119669544_119672401 | 9.84 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr10_97566192_97567945 | 9.83 |
Lum |
lumican |
1940 |
0.32 |
chr8_23035959_23037041 | 9.81 |
Ank1 |
ankyrin 1, erythroid |
1269 |
0.45 |
chr6_127581934_127583022 | 9.79 |
Cracr2a |
calcium release activated channel regulator 2A |
4503 |
0.24 |
chr6_122391330_122392825 | 9.77 |
1700063H04Rik |
RIKEN cDNA 1700063H04 gene |
698 |
0.58 |
chr4_107606091_107606811 | 9.77 |
Glis1 |
GLIS family zinc finger 1 |
8549 |
0.19 |
chr12_73044500_73046647 | 9.71 |
Six1 |
sine oculis-related homeobox 1 |
282 |
0.92 |
chr5_107724563_107727169 | 9.70 |
Gfi1 |
growth factor independent 1 transcription repressor |
61 |
0.88 |
chr11_102360845_102363484 | 9.67 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
1540 |
0.24 |
chr8_84836764_84838739 | 9.64 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
296 |
0.75 |
chr2_170153321_170154276 | 9.62 |
Zfp217 |
zinc finger protein 217 |
5695 |
0.31 |
chr7_142576289_142578620 | 9.62 |
H19 |
H19, imprinted maternally expressed transcript |
68 |
0.78 |
chr18_56870048_56870991 | 9.60 |
Gm18087 |
predicted gene, 18087 |
45569 |
0.14 |
chr18_78122352_78123104 | 9.51 |
Slc14a1 |
solute carrier family 14 (urea transporter), member 1 |
603 |
0.79 |
chr14_55061871_55064122 | 9.45 |
Gm20687 |
predicted gene 20687 |
7503 |
0.08 |
chr8_124569006_124569716 | 9.44 |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
345 |
0.86 |
chr3_100485235_100486511 | 9.43 |
Tent5c |
terminal nucleotidyltransferase 5C |
3321 |
0.18 |
chr19_4058692_4059651 | 9.39 |
Gstp3 |
glutathione S-transferase pi 3 |
124 |
0.88 |
chr2_105125289_105128976 | 9.38 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr5_75148315_75152589 | 9.36 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr10_25298003_25298350 | 9.35 |
Gm40617 |
predicted gene, 40617 |
433 |
0.68 |
chr6_90619935_90620303 | 9.27 |
Slc41a3 |
solute carrier family 41, member 3 |
972 |
0.47 |
chr3_137968340_137969523 | 9.26 |
Dapp1 |
dual adaptor for phosphotyrosine and 3-phosphoinositides 1 |
12599 |
0.12 |
chr3_84269309_84270900 | 9.25 |
Trim2 |
tripartite motif-containing 2 |
687 |
0.77 |
chr12_85686314_85687645 | 9.24 |
Batf |
basic leucine zipper transcription factor, ATF-like |
310 |
0.85 |
chr1_87620304_87621692 | 9.23 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
371 |
0.85 |
chr18_32557788_32558922 | 9.17 |
Gypc |
glycophorin C |
1625 |
0.41 |
chr7_143005165_143005465 | 9.16 |
Tspan32 |
tetraspanin 32 |
171 |
0.92 |
chr8_71665120_71666309 | 9.15 |
Unc13a |
unc-13 homolog A |
2368 |
0.14 |
chr7_127136253_127136989 | 9.12 |
Spn |
sialophorin |
55 |
0.93 |
chr14_118796451_118797209 | 9.09 |
Cldn10 |
claudin 10 |
8912 |
0.16 |
chr5_34976674_34977152 | 9.08 |
Rgs12 |
regulator of G-protein signaling 12 |
1921 |
0.31 |
chr2_84843620_84843993 | 9.07 |
Slc43a1 |
solute carrier family 43, member 1 |
3181 |
0.15 |
chr4_144892505_144894616 | 9.03 |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
341 |
0.9 |
chr8_94976904_94978618 | 8.95 |
Adgrg1 |
adhesion G protein-coupled receptor G1 |
652 |
0.59 |
chr10_115817324_115818606 | 8.92 |
Tspan8 |
tetraspanin 8 |
681 |
0.78 |
chr4_109405488_109405928 | 8.90 |
Ttc39aos1 |
Ttc39a opposite strand RNA 1 |
447 |
0.66 |
chr12_111442182_111444685 | 8.87 |
Tnfaip2 |
tumor necrosis factor, alpha-induced protein 2 |
771 |
0.51 |
chr15_58594635_58595816 | 8.82 |
Fer1l6 |
fer-1-like 6 (C. elegans) |
43280 |
0.17 |
chr15_73750483_73751713 | 8.81 |
Ptp4a3 |
protein tyrosine phosphatase 4a3 |
2724 |
0.24 |
chr4_135896003_135896554 | 8.75 |
Cnr2 |
cannabinoid receptor 2 (macrophage) |
884 |
0.41 |
chr1_174173964_174174767 | 8.71 |
Spta1 |
spectrin alpha, erythrocytic 1 |
1589 |
0.22 |
chr6_115758043_115758599 | 8.71 |
Tmem40 |
transmembrane protein 40 |
678 |
0.53 |
chr5_114969022_114970855 | 8.68 |
Hnf1aos1 |
HNF1 homeobox A, opposite strand 1 |
18 |
0.91 |
chr2_93353181_93353959 | 8.65 |
Tspan18 |
tetraspanin 18 |
19065 |
0.16 |
chr11_98581326_98581888 | 8.64 |
Ormdl3 |
ORM1-like 3 (S. cerevisiae) |
5761 |
0.11 |
chr9_108104524_108105208 | 8.57 |
Gm47303 |
predicted gene, 47303 |
1620 |
0.16 |
chr16_32176859_32178095 | 8.56 |
Bex6 |
brain expressed family member 6 |
2346 |
0.2 |
chr3_152314712_152314923 | 8.56 |
Miga1 |
mitoguardin 1 |
2898 |
0.19 |
chr4_62516521_62517025 | 8.56 |
Alad |
aminolevulinate, delta-, dehydratase |
3108 |
0.15 |
chr5_120138122_120139268 | 8.51 |
Gm10390 |
predicted gene 10390 |
566 |
0.77 |
chr15_31568293_31569667 | 8.51 |
Cmbl |
carboxymethylenebutenolidase-like (Pseudomonas) |
182 |
0.92 |
chr10_62326596_62327258 | 8.47 |
Hk1 |
hexokinase 1 |
840 |
0.58 |
chr9_21963175_21963912 | 8.44 |
Epor |
erythropoietin receptor |
37 |
0.94 |
chr7_99824758_99826479 | 8.44 |
Neu3 |
neuraminidase 3 |
2799 |
0.17 |
chr7_5029343_5032174 | 8.44 |
Zfp865 |
zinc finger protein 865 |
1434 |
0.15 |
chr2_146834060_146838027 | 8.41 |
Gm14114 |
predicted gene 14114 |
3689 |
0.27 |
chr18_64484992_64485250 | 8.41 |
Fech |
ferrochelatase |
3820 |
0.19 |
chr7_4629257_4630354 | 8.41 |
Tmem86b |
transmembrane protein 86B |
382 |
0.66 |
chr2_104098689_104099469 | 8.34 |
Cd59a |
CD59a antigen |
3239 |
0.16 |
chr11_120628644_120631479 | 8.30 |
Mafg |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein G (avian) |
87 |
0.89 |
chr3_106788400_106790067 | 8.30 |
Cd53 |
CD53 antigen |
916 |
0.58 |
chr3_83008148_83008803 | 8.29 |
Gm30097 |
predicted gene, 30097 |
13 |
0.92 |
chr10_80569864_80570541 | 8.27 |
Klf16 |
Kruppel-like factor 16 |
7119 |
0.08 |
chr10_80016553_80017516 | 8.26 |
Arhgap45 |
Rho GTPase activating protein 45 |
118 |
0.91 |
chr11_102357545_102358717 | 8.24 |
Slc4a1 |
solute carrier family 4 (anion exchanger), member 1 |
2437 |
0.16 |
chr9_44340460_44342952 | 8.21 |
Hmbs |
hydroxymethylbilane synthase |
473 |
0.51 |
chr4_130252226_130252946 | 8.19 |
Serinc2 |
serine incorporator 2 |
22632 |
0.13 |
chrX_85613609_85614890 | 8.19 |
Gm44378 |
predicted gene, 44378 |
25272 |
0.18 |
chr7_79841260_79842229 | 8.15 |
Anpep |
alanyl (membrane) aminopeptidase |
608 |
0.6 |
chr7_75595593_75596793 | 8.14 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
13846 |
0.19 |
chr16_94370781_94372079 | 8.13 |
Pigp |
phosphatidylinositol glycan anchor biosynthesis, class P |
412 |
0.57 |
chr8_23034845_23035677 | 8.13 |
Ank1 |
ankyrin 1, erythroid |
30 |
0.98 |
chr9_66988141_66989423 | 8.09 |
Gm24225 |
predicted gene, 24225 |
7597 |
0.16 |
chr1_164151644_164152602 | 8.07 |
Gm16548 |
predicted gene 16548 |
94 |
0.74 |
chr11_103102696_103105788 | 8.04 |
Acbd4 |
acyl-Coenzyme A binding domain containing 4 |
463 |
0.7 |
chr13_23308326_23310444 | 8.04 |
4930557F10Rik |
RIKEN cDNA 4930557F10 gene |
4015 |
0.1 |
chr1_37478065_37479166 | 8.03 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9990 |
0.14 |
chr6_146220162_146220523 | 7.99 |
Itpr2 |
inositol 1,4,5-triphosphate receptor 2 |
7201 |
0.26 |
chr8_85380167_85381092 | 7.98 |
Mylk3 |
myosin light chain kinase 3 |
349 |
0.83 |
chr2_26016837_26017543 | 7.98 |
Ubac1 |
ubiquitin associated domain containing 1 |
288 |
0.86 |
chr7_75612178_75613652 | 7.97 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
631 |
0.75 |
chr4_53143397_53144061 | 7.97 |
Abca1 |
ATP-binding cassette, sub-family A (ABC1), member 1 |
16166 |
0.21 |
chr9_105520039_105521535 | 7.96 |
Atp2c1 |
ATPase, Ca++-sequestering |
360 |
0.86 |
chr7_24369840_24369991 | 7.95 |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
348 |
0.74 |
chr3_135607346_135607932 | 7.94 |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 |
631 |
0.72 |
chr2_20736484_20738247 | 7.92 |
Etl4 |
enhancer trap locus 4 |
51 |
0.98 |
chr8_13202008_13202379 | 7.92 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
1373 |
0.23 |
chr5_33032002_33032722 | 7.91 |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
10571 |
0.14 |
chr14_69493829_69494689 | 7.90 |
Gm37094 |
predicted gene, 37094 |
6131 |
0.11 |
chr14_69275580_69276440 | 7.88 |
Gm20236 |
predicted gene, 20236 |
6130 |
0.1 |
chr2_180724979_180726144 | 7.88 |
Slc17a9 |
solute carrier family 17, member 9 |
161 |
0.92 |
chr15_67127618_67128557 | 7.87 |
St3gal1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1 |
936 |
0.68 |
chr11_119671153_119671590 | 7.87 |
Rptor |
regulatory associated protein of MTOR, complex 1 |
15427 |
0.17 |
chr2_104097569_104098085 | 7.82 |
Cd59a |
CD59a antigen |
1987 |
0.22 |
chr4_49548394_49548727 | 7.82 |
Aldob |
aldolase B, fructose-bisphosphate |
986 |
0.46 |
chr8_122546551_122549259 | 7.82 |
Piezo1 |
piezo-type mechanosensitive ion channel component 1 |
3424 |
0.12 |
chr18_39485704_39487567 | 7.82 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
597 |
0.82 |
chr4_133871871_133872343 | 7.81 |
Rps6ka1 |
ribosomal protein S6 kinase polypeptide 1 |
206 |
0.57 |
chr8_13202537_13203450 | 7.81 |
2810030D12Rik |
RIKEN cDNA 2810030D12 gene |
2173 |
0.16 |
chr12_109455257_109457986 | 7.78 |
Dlk1 |
delta like non-canonical Notch ligand 1 |
2426 |
0.16 |
chr9_41072966_41074089 | 7.74 |
Ubash3b |
ubiquitin associated and SH3 domain containing, B |
5979 |
0.19 |
chr13_59766981_59767805 | 7.74 |
Isca1 |
iron-sulfur cluster assembly 1 |
2084 |
0.13 |
chr15_103253562_103255772 | 7.72 |
Nfe2 |
nuclear factor, erythroid derived 2 |
605 |
0.57 |
chr13_24501559_24502461 | 7.72 |
Ripor2 |
RHO family interacting cell polarization regulator 2 |
485 |
0.79 |
chr19_10015065_10016667 | 7.72 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
822 |
0.48 |
chr8_84703616_84705950 | 7.72 |
Nfix |
nuclear factor I/X |
2933 |
0.13 |
chr18_62176067_62177775 | 7.71 |
Adrb2 |
adrenergic receptor, beta 2 |
3038 |
0.24 |
chr15_102150305_102151233 | 7.71 |
Soat2 |
sterol O-acyltransferase 2 |
243 |
0.86 |
chr6_136857054_136858156 | 7.70 |
Art4 |
ADP-ribosyltransferase 4 |
128 |
0.92 |
chr1_132365874_132366736 | 7.70 |
Tmcc2 |
transmembrane and coiled-coil domains 2 |
767 |
0.54 |
chr15_78571734_78572724 | 7.69 |
Rac2 |
Rac family small GTPase 2 |
552 |
0.62 |
chr6_135362982_135365483 | 7.68 |
Emp1 |
epithelial membrane protein 1 |
1164 |
0.42 |
chr6_23131783_23132150 | 7.67 |
Aass |
aminoadipate-semialdehyde synthase |
950 |
0.5 |
chr3_21987826_21988387 | 7.67 |
Gm43674 |
predicted gene 43674 |
10362 |
0.21 |
chr2_173024069_173026002 | 7.63 |
Rbm38 |
RNA binding motif protein 38 |
1985 |
0.21 |
chr7_48937652_48937978 | 7.57 |
Gm18559 |
predicted gene, 18559 |
2303 |
0.24 |
chr2_127364227_127365175 | 7.57 |
Adra2b |
adrenergic receptor, alpha 2b |
1415 |
0.34 |
chr11_95833615_95836077 | 7.54 |
Abi3 |
ABI gene family, member 3 |
1044 |
0.33 |
chr2_26019769_26020174 | 7.53 |
Ubac1 |
ubiquitin associated domain containing 1 |
1561 |
0.29 |
chr11_102145120_102148094 | 7.53 |
Nags |
N-acetylglutamate synthase |
241 |
0.58 |
chr15_100420340_100420713 | 7.53 |
Gm5475 |
predicted gene 5475 |
1621 |
0.23 |
chr12_117657998_117660727 | 7.52 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
1328 |
0.51 |
chr10_127511678_127514192 | 7.52 |
Ndufa4l2 |
Ndufa4, mitochondrial complex associated like 2 |
2032 |
0.18 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
12.9 | 38.8 | GO:0071336 | regulation of hair follicle cell proliferation(GO:0071336) |
7.2 | 7.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
6.9 | 20.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
6.9 | 20.7 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
6.3 | 19.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
5.8 | 17.4 | GO:0072095 | regulation of branch elongation involved in ureteric bud branching(GO:0072095) |
5.8 | 17.3 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
5.5 | 22.2 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
5.3 | 15.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
5.2 | 25.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
5.1 | 20.6 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
5.1 | 20.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
5.1 | 15.2 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
4.9 | 24.7 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
4.9 | 14.8 | GO:0010159 | specification of organ position(GO:0010159) |
4.8 | 4.8 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
4.7 | 14.2 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
4.4 | 13.3 | GO:0035483 | gastric emptying(GO:0035483) |
4.3 | 4.3 | GO:0070627 | ferrous iron import(GO:0070627) |
4.3 | 4.3 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
4.3 | 12.8 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
4.2 | 16.9 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
4.1 | 99.5 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
4.1 | 16.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
4.0 | 12.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
4.0 | 11.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.9 | 11.6 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
3.7 | 7.4 | GO:0048793 | pronephros development(GO:0048793) |
3.7 | 3.7 | GO:0034395 | regulation of transcription from RNA polymerase II promoter in response to iron(GO:0034395) |
3.6 | 10.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
3.6 | 10.8 | GO:0061511 | centriole elongation(GO:0061511) |
3.6 | 14.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
3.5 | 10.5 | GO:1900200 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
3.5 | 10.4 | GO:0046149 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.5 | 20.8 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
3.4 | 6.7 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
3.3 | 10.0 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
3.3 | 13.3 | GO:0032264 | IMP salvage(GO:0032264) |
3.3 | 6.6 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
3.3 | 9.8 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
3.3 | 9.8 | GO:0001798 | type IIa hypersensitivity(GO:0001794) regulation of type IIa hypersensitivity(GO:0001796) positive regulation of type IIa hypersensitivity(GO:0001798) type II hypersensitivity(GO:0002445) regulation of type II hypersensitivity(GO:0002892) positive regulation of type II hypersensitivity(GO:0002894) |
3.3 | 6.5 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
3.2 | 9.7 | GO:0002432 | granuloma formation(GO:0002432) |
3.2 | 12.7 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
3.1 | 9.2 | GO:0050904 | diapedesis(GO:0050904) |
3.1 | 9.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
3.1 | 15.3 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
3.0 | 6.0 | GO:0003331 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
3.0 | 15.1 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
3.0 | 12.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
3.0 | 9.0 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
2.9 | 8.8 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
2.9 | 11.7 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
2.9 | 17.3 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
2.9 | 11.5 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
2.9 | 5.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
2.8 | 19.8 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
2.8 | 8.5 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
2.8 | 8.5 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
2.8 | 14.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
2.8 | 13.9 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.8 | 11.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
2.7 | 19.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
2.7 | 8.2 | GO:0008228 | opsonization(GO:0008228) |
2.7 | 8.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
2.6 | 10.5 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
2.6 | 7.9 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
2.6 | 7.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
2.6 | 2.6 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
2.6 | 2.6 | GO:2000482 | regulation of interleukin-8 secretion(GO:2000482) |
2.6 | 2.6 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
2.6 | 2.6 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
2.5 | 7.6 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
2.5 | 7.6 | GO:0061624 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.5 | 7.5 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
2.5 | 2.5 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
2.5 | 5.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
2.5 | 9.9 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
2.5 | 9.9 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.4 | 4.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
2.4 | 14.6 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
2.4 | 4.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
2.4 | 2.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.4 | 9.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
2.4 | 14.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
2.3 | 7.0 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
2.3 | 18.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
2.3 | 18.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
2.3 | 11.4 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
2.3 | 6.8 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
2.3 | 6.8 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.2 | 11.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
2.2 | 4.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
2.2 | 6.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
2.2 | 4.4 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.2 | 28.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
2.2 | 10.9 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
2.2 | 6.6 | GO:0001905 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.2 | 4.4 | GO:0060767 | epithelial cell proliferation involved in prostate gland development(GO:0060767) regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
2.2 | 8.7 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
2.2 | 8.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
2.2 | 6.5 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
2.1 | 4.2 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
2.1 | 4.2 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
2.1 | 6.3 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
2.1 | 2.1 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
2.1 | 6.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
2.1 | 8.3 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
2.1 | 6.2 | GO:0009197 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
2.0 | 6.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
2.0 | 6.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
2.0 | 5.9 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) |
2.0 | 7.9 | GO:0070836 | caveola assembly(GO:0070836) |
2.0 | 3.9 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
2.0 | 19.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
1.9 | 9.7 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
1.9 | 5.8 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
1.9 | 13.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
1.9 | 9.5 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
1.9 | 5.7 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
1.9 | 3.8 | GO:0072276 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
1.9 | 5.6 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
1.9 | 13.2 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
1.9 | 9.4 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.9 | 1.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
1.9 | 1.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
1.9 | 11.1 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
1.9 | 3.7 | GO:0042908 | xenobiotic transport(GO:0042908) |
1.9 | 13.0 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
1.8 | 1.8 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
1.8 | 3.7 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
1.8 | 7.3 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
1.8 | 5.5 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
1.8 | 3.6 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
1.8 | 1.8 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.8 | 14.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
1.8 | 3.6 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
1.8 | 1.8 | GO:0052490 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
1.8 | 3.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
1.8 | 5.3 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
1.8 | 1.8 | GO:0009189 | deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) |
1.8 | 1.8 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
1.7 | 8.7 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.7 | 7.0 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
1.7 | 5.2 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.7 | 1.7 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
1.7 | 5.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
1.7 | 10.3 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
1.7 | 5.1 | GO:0061010 | gall bladder development(GO:0061010) |
1.7 | 10.2 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
1.7 | 6.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
1.7 | 5.0 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
1.7 | 1.7 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
1.6 | 9.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.6 | 8.2 | GO:0015879 | carnitine transport(GO:0015879) |
1.6 | 3.3 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of removal of superoxide radicals(GO:1904833) |
1.6 | 6.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.6 | 4.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
1.6 | 4.9 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
1.6 | 1.6 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
1.6 | 3.2 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
1.6 | 6.4 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
1.6 | 1.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
1.6 | 9.6 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
1.6 | 4.8 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.6 | 28.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.6 | 4.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.6 | 7.9 | GO:1903912 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
1.6 | 9.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
1.6 | 9.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
1.6 | 9.4 | GO:0034433 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.6 | 3.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
1.6 | 4.7 | GO:0009629 | response to gravity(GO:0009629) |
1.6 | 10.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.6 | 1.6 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
1.5 | 3.1 | GO:0006901 | vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
1.5 | 1.5 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
1.5 | 4.6 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.5 | 3.1 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
1.5 | 6.1 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
1.5 | 3.1 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.5 | 4.6 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
1.5 | 1.5 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
1.5 | 6.1 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.5 | 6.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
1.5 | 11.9 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.5 | 7.4 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
1.5 | 5.9 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
1.5 | 8.9 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
1.5 | 5.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
1.5 | 4.4 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
1.5 | 23.3 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
1.5 | 2.9 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.4 | 11.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
1.4 | 5.8 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
1.4 | 2.9 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.4 | 2.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.4 | 5.7 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.4 | 11.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
1.4 | 8.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
1.4 | 17.1 | GO:0051601 | exocyst localization(GO:0051601) |
1.4 | 11.4 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.4 | 7.1 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.4 | 5.7 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.4 | 2.8 | GO:0008207 | C21-steroid hormone metabolic process(GO:0008207) |
1.4 | 4.2 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.4 | 4.2 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.4 | 1.4 | GO:0001923 | B-1 B cell differentiation(GO:0001923) B-1a B cell differentiation(GO:0002337) |
1.4 | 2.8 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
1.4 | 5.6 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
1.4 | 6.9 | GO:0006000 | fructose metabolic process(GO:0006000) |
1.4 | 4.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
1.4 | 1.4 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
1.4 | 8.2 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.4 | 4.1 | GO:0045897 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
1.4 | 1.4 | GO:0035740 | CD8-positive, alpha-beta T cell proliferation(GO:0035740) |
1.4 | 2.7 | GO:1902075 | cellular response to salt(GO:1902075) |
1.4 | 4.1 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
1.4 | 1.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
1.4 | 9.5 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
1.3 | 17.5 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
1.3 | 1.3 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
1.3 | 4.0 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
1.3 | 6.7 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
1.3 | 5.4 | GO:0032776 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.3 | 1.3 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
1.3 | 1.3 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
1.3 | 4.0 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
1.3 | 1.3 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
1.3 | 1.3 | GO:0034115 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
1.3 | 13.1 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.3 | 3.9 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
1.3 | 2.6 | GO:0072718 | response to cisplatin(GO:0072718) |
1.3 | 2.6 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.3 | 20.9 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
1.3 | 5.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.3 | 1.3 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
1.3 | 3.9 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.3 | 3.8 | GO:0018343 | protein farnesylation(GO:0018343) |
1.3 | 3.8 | GO:0006116 | NADH oxidation(GO:0006116) |
1.3 | 1.3 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
1.3 | 17.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
1.3 | 6.3 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.3 | 1.3 | GO:0032621 | interleukin-18 production(GO:0032621) |
1.3 | 7.5 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
1.3 | 1.3 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
1.3 | 3.8 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.2 | 3.7 | GO:2000389 | regulation of neutrophil extravasation(GO:2000389) positive regulation of neutrophil extravasation(GO:2000391) |
1.2 | 3.7 | GO:1904683 | regulation of metalloendopeptidase activity(GO:1904683) negative regulation of metalloendopeptidase activity(GO:1904684) negative regulation of metallopeptidase activity(GO:1905049) |
1.2 | 9.9 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
1.2 | 1.2 | GO:0035973 | aggrephagy(GO:0035973) |
1.2 | 7.3 | GO:0032782 | bile acid secretion(GO:0032782) |
1.2 | 13.4 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.2 | 14.5 | GO:0048821 | erythrocyte development(GO:0048821) |
1.2 | 3.6 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
1.2 | 3.6 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.2 | 4.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
1.2 | 3.6 | GO:0008050 | female courtship behavior(GO:0008050) |
1.2 | 8.3 | GO:0015825 | L-serine transport(GO:0015825) |
1.2 | 3.5 | GO:0043173 | nucleotide salvage(GO:0043173) |
1.2 | 10.6 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
1.2 | 1.2 | GO:0070673 | response to interleukin-18(GO:0070673) cellular response to interleukin-18(GO:0071351) |
1.2 | 4.7 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.2 | 2.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.2 | 3.5 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.2 | 3.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
1.2 | 16.2 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
1.2 | 3.5 | GO:0046208 | spermine catabolic process(GO:0046208) |
1.2 | 3.5 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
1.2 | 2.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.1 | 3.4 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
1.1 | 5.7 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.1 | 6.9 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
1.1 | 20.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
1.1 | 4.6 | GO:0044004 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
1.1 | 2.3 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
1.1 | 9.1 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
1.1 | 3.4 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.1 | 4.5 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
1.1 | 15.8 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
1.1 | 3.4 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.1 | 4.5 | GO:0016139 | glycoside catabolic process(GO:0016139) |
1.1 | 2.2 | GO:0072672 | neutrophil extravasation(GO:0072672) |
1.1 | 4.5 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
1.1 | 4.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.1 | 2.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.1 | 6.6 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.1 | 5.5 | GO:0010991 | negative regulation of SMAD protein complex assembly(GO:0010991) |
1.1 | 8.8 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
1.1 | 16.3 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
1.1 | 2.2 | GO:0060921 | sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
1.1 | 4.3 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
1.1 | 4.3 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.1 | 4.3 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
1.1 | 10.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.1 | 3.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
1.1 | 1.1 | GO:0065001 | specification of axis polarity(GO:0065001) |
1.1 | 1.1 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
1.1 | 13.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.1 | 6.4 | GO:0044351 | macropinocytosis(GO:0044351) |
1.1 | 2.1 | GO:0060056 | mammary gland involution(GO:0060056) |
1.1 | 1.1 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
1.1 | 1.1 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
1.1 | 5.3 | GO:0018904 | ether metabolic process(GO:0018904) |
1.1 | 3.2 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.1 | 4.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
1.1 | 2.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
1.1 | 8.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.1 | 4.2 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
1.0 | 4.2 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
1.0 | 9.4 | GO:0032060 | bleb assembly(GO:0032060) |
1.0 | 10.5 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.0 | 3.1 | GO:2000489 | regulation of hepatic stellate cell activation(GO:2000489) |
1.0 | 28.2 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.0 | 6.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
1.0 | 4.2 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
1.0 | 2.1 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.0 | 4.2 | GO:1904667 | negative regulation of ubiquitin protein ligase activity(GO:1904667) |
1.0 | 2.1 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
1.0 | 3.1 | GO:0030952 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
1.0 | 4.1 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.0 | 9.2 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.0 | 5.1 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
1.0 | 1.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.0 | 5.1 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
1.0 | 3.1 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
1.0 | 2.0 | GO:2000978 | regulation of forebrain neuron differentiation(GO:2000977) negative regulation of forebrain neuron differentiation(GO:2000978) |
1.0 | 9.2 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
1.0 | 1.0 | GO:0036258 | multivesicular body assembly(GO:0036258) |
1.0 | 3.1 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
1.0 | 2.0 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.0 | 1.0 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
1.0 | 1.0 | GO:0060847 | endothelial cell fate specification(GO:0060847) |
1.0 | 6.0 | GO:0051352 | negative regulation of ligase activity(GO:0051352) |
1.0 | 19.1 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.0 | 1.0 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.0 | 5.0 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
1.0 | 3.0 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.0 | 6.9 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
1.0 | 2.0 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
1.0 | 5.9 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.0 | 12.8 | GO:0006465 | signal peptide processing(GO:0006465) |
1.0 | 2.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.0 | 2.0 | GO:0042117 | monocyte activation(GO:0042117) |
1.0 | 2.9 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.0 | 1.9 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
1.0 | 8.7 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
1.0 | 3.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.0 | 5.8 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.0 | 5.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
1.0 | 2.9 | GO:0034123 | positive regulation of toll-like receptor signaling pathway(GO:0034123) |
1.0 | 5.8 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
1.0 | 7.7 | GO:0046415 | urate metabolic process(GO:0046415) |
1.0 | 2.9 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.0 | 4.8 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
1.0 | 1.9 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
1.0 | 5.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.0 | 1.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
1.0 | 1.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
1.0 | 1.0 | GO:1902965 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.0 | 6.7 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.9 | 4.7 | GO:0031659 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle(GO:0031659) |
0.9 | 6.6 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.9 | 3.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
0.9 | 8.5 | GO:0070269 | pyroptosis(GO:0070269) |
0.9 | 1.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.9 | 0.9 | GO:0060143 | positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
0.9 | 2.8 | GO:0010727 | negative regulation of hydrogen peroxide metabolic process(GO:0010727) |
0.9 | 2.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.9 | 6.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.9 | 0.9 | GO:0007494 | midgut development(GO:0007494) |
0.9 | 2.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.9 | 1.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.9 | 2.8 | GO:0071926 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.9 | 5.6 | GO:0006477 | protein sulfation(GO:0006477) |
0.9 | 0.9 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.9 | 5.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.9 | 1.8 | GO:0032966 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) |
0.9 | 8.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.9 | 0.9 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.9 | 1.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
0.9 | 6.3 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.9 | 0.9 | GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) |
0.9 | 3.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.9 | 2.7 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.9 | 0.9 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.9 | 3.6 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.9 | 7.2 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.9 | 2.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.9 | 0.9 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.9 | 0.9 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
0.9 | 0.9 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.9 | 2.7 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.9 | 1.8 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.9 | 0.9 | GO:0003071 | renal system process involved in regulation of systemic arterial blood pressure(GO:0003071) |
0.9 | 2.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.9 | 2.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
0.9 | 3.5 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.9 | 1.8 | GO:0032831 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.9 | 1.8 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
0.9 | 4.4 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.9 | 10.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.9 | 6.1 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
0.9 | 2.6 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.9 | 5.2 | GO:0042168 | heme metabolic process(GO:0042168) |
0.9 | 0.9 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
0.9 | 0.9 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.9 | 15.6 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.9 | 4.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.9 | 11.3 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) |
0.9 | 6.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.9 | 3.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.9 | 1.7 | GO:0002069 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) |
0.9 | 2.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.9 | 1.7 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.9 | 1.7 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.9 | 3.4 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.9 | 1.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.9 | 0.9 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.9 | 2.6 | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway(GO:0038089) |
0.9 | 1.7 | GO:0036302 | atrioventricular canal development(GO:0036302) |
0.9 | 2.6 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.8 | 2.5 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 2.5 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.8 | 0.8 | GO:0071276 | cellular response to cadmium ion(GO:0071276) |
0.8 | 1.7 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.8 | 1.7 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.8 | 0.8 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.8 | 4.2 | GO:0060099 | regulation of phagocytosis, engulfment(GO:0060099) |
0.8 | 0.8 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.8 | 0.8 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
0.8 | 2.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.8 | 0.8 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
0.8 | 2.5 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.8 | 5.0 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.8 | 5.8 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.8 | 4.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.8 | 19.7 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.8 | 2.5 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.8 | 3.3 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.8 | 0.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.8 | 1.6 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.8 | 0.8 | GO:0071800 | podosome assembly(GO:0071800) |
0.8 | 9.0 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.8 | 4.1 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.8 | 0.8 | GO:2000321 | positive regulation of T-helper 17 cell differentiation(GO:2000321) |
0.8 | 7.3 | GO:0030575 | nuclear body organization(GO:0030575) |
0.8 | 1.6 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.8 | 2.4 | GO:0019287 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.8 | 1.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.8 | 3.2 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.8 | 2.4 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.8 | 2.4 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.8 | 4.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.8 | 3.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.8 | 5.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.8 | 4.0 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.8 | 3.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.8 | 4.0 | GO:0060613 | fat pad development(GO:0060613) |
0.8 | 0.8 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.8 | 0.8 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.8 | 10.2 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.8 | 6.3 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.8 | 1.6 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.8 | 11.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.8 | 1.6 | GO:0071921 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.8 | 0.8 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.8 | 3.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.8 | 0.8 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.8 | 6.9 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.8 | 1.5 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.8 | 1.5 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.8 | 0.8 | GO:1904673 | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072039) negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:0072040) kidney mesenchyme morphogenesis(GO:0072131) metanephric mesenchyme morphogenesis(GO:0072133) mesenchymal cell apoptotic process involved in nephron morphogenesis(GO:1901145) regulation of somatic stem cell population maintenance(GO:1904672) negative regulation of somatic stem cell population maintenance(GO:1904673) |
0.8 | 3.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.8 | 5.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.8 | 3.8 | GO:0036336 | dendritic cell migration(GO:0036336) |
0.8 | 3.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.8 | 2.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.8 | 6.0 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.8 | 4.5 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.8 | 3.8 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.7 | 0.7 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.7 | 6.0 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.7 | 4.5 | GO:0090196 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
0.7 | 0.7 | GO:0045416 | positive regulation of interleukin-8 biosynthetic process(GO:0045416) |
0.7 | 3.7 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 3.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.7 | 2.2 | GO:0019532 | oxalate transport(GO:0019532) |
0.7 | 6.7 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.7 | 0.7 | GO:0044783 | G1 DNA damage checkpoint(GO:0044783) |
0.7 | 2.2 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.7 | 2.2 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.7 | 4.4 | GO:0046688 | response to copper ion(GO:0046688) |
0.7 | 1.5 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.7 | 5.1 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.7 | 13.2 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.7 | 5.1 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.7 | 5.1 | GO:0045986 | negative regulation of smooth muscle contraction(GO:0045986) |
0.7 | 2.2 | GO:0072711 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.7 | 0.7 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.7 | 2.2 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.7 | 0.7 | GO:0060426 | lung vasculature development(GO:0060426) |
0.7 | 0.7 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.7 | 3.6 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.7 | 4.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.7 | 7.2 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.7 | 2.2 | GO:1903299 | negative regulation of glucokinase activity(GO:0033132) regulation of hexokinase activity(GO:1903299) negative regulation of hexokinase activity(GO:1903300) |
0.7 | 2.9 | GO:2000637 | positive regulation of gene silencing by miRNA(GO:2000637) |
0.7 | 3.6 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.7 | 2.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.7 | 2.9 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.7 | 2.9 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.7 | 2.1 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.7 | 12.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.7 | 2.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.7 | 2.1 | GO:0061157 | RNA destabilization(GO:0050779) mRNA destabilization(GO:0061157) |
0.7 | 1.4 | GO:0045916 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.7 | 1.4 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.7 | 2.1 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.7 | 3.5 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.7 | 4.9 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
0.7 | 2.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.7 | 5.6 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 1.4 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
0.7 | 2.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.7 | 2.8 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.7 | 4.2 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.7 | 2.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.7 | 2.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.7 | 1.4 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.7 | 2.1 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.7 | 8.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.7 | 6.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.7 | 11.7 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.7 | 3.4 | GO:0018101 | protein citrullination(GO:0018101) |
0.7 | 4.1 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.7 | 1.4 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.7 | 0.7 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.7 | 2.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.7 | 1.4 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.7 | 4.1 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.7 | 2.0 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.7 | 2.0 | GO:0048539 | bone marrow development(GO:0048539) |
0.7 | 4.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.7 | 0.7 | GO:0032647 | regulation of interferon-alpha production(GO:0032647) |
0.7 | 2.7 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.7 | 16.1 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.7 | 1.3 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.7 | 1.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.7 | 0.7 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.7 | 0.7 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
0.7 | 2.0 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.7 | 4.0 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.7 | 0.7 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.7 | 1.3 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.7 | 2.7 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.7 | 3.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.7 | 11.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.7 | 1.3 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.7 | 2.0 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.7 | 6.6 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.7 | 9.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.7 | 1.3 | GO:0030421 | defecation(GO:0030421) |
0.7 | 3.3 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.7 | 0.7 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.7 | 7.8 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.6 | 1.9 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
0.6 | 14.3 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.6 | 3.9 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.6 | 1.9 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 1.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.6 | 1.9 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) |
0.6 | 3.9 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.6 | 3.9 | GO:0032717 | negative regulation of interleukin-8 production(GO:0032717) |
0.6 | 4.5 | GO:0030851 | granulocyte differentiation(GO:0030851) |
0.6 | 3.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.6 | 0.6 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.6 | 0.6 | GO:0045588 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.6 | 1.3 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
0.6 | 1.3 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) negative regulation of complement-dependent cytotoxicity(GO:1903660) |
0.6 | 0.6 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.6 | 1.3 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.6 | 3.8 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.6 | 0.6 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.6 | 1.9 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
0.6 | 1.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.6 | 1.9 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.6 | 10.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.6 | 12.7 | GO:0006491 | N-glycan processing(GO:0006491) |
0.6 | 1.9 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.6 | 0.6 | GO:0051882 | mitochondrial depolarization(GO:0051882) regulation of mitochondrial depolarization(GO:0051900) |
0.6 | 0.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.6 | 1.9 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.6 | 2.5 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.6 | 3.8 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.6 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.6 | 1.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.6 | 5.0 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.6 | 1.3 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.6 | 1.9 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.6 | 0.6 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.6 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.6 | 3.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 1.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.6 | 0.6 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
0.6 | 1.2 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.6 | 5.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.6 | 0.6 | GO:1902403 | signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.6 | 1.8 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.6 | 2.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.6 | 3.1 | GO:1902414 | protein localization to cell junction(GO:1902414) |
0.6 | 0.6 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.6 | 2.4 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.6 | 1.8 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.6 | 0.6 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.6 | 0.6 | GO:0031100 | organ regeneration(GO:0031100) |
0.6 | 5.4 | GO:0006560 | proline metabolic process(GO:0006560) |
0.6 | 6.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.6 | 4.2 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.6 | 1.2 | GO:0098532 | histone H3-K27 trimethylation(GO:0098532) |
0.6 | 4.2 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.6 | 3.0 | GO:0001842 | neural fold formation(GO:0001842) |
0.6 | 2.4 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.6 | 9.6 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.6 | 1.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.6 | 1.2 | GO:0033033 | negative regulation of myeloid cell apoptotic process(GO:0033033) |
0.6 | 4.8 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.6 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.6 | 1.8 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.6 | 4.2 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.6 | 1.8 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.6 | 1.2 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 2.4 | GO:0010226 | response to lithium ion(GO:0010226) |
0.6 | 1.8 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.6 | 2.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.6 | 19.3 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.6 | 0.6 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.6 | 5.8 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.6 | 4.7 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.6 | 2.3 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.6 | 1.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.6 | 2.9 | GO:0044117 | growth involved in symbiotic interaction(GO:0044110) growth of symbiont involved in interaction with host(GO:0044116) growth of symbiont in host(GO:0044117) |
0.6 | 0.6 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.6 | 2.3 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
0.6 | 0.6 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
0.6 | 2.9 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.6 | 1.7 | GO:0065005 | protein-lipid complex assembly(GO:0065005) |
0.6 | 1.7 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.6 | 6.8 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.6 | 1.7 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.6 | 3.4 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.6 | 1.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.6 | 1.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.6 | 3.4 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.6 | 1.7 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.6 | 1.1 | GO:0031577 | spindle checkpoint(GO:0031577) |
0.6 | 1.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.6 | 17.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.6 | 1.7 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.6 | 1.7 | GO:0035093 | spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
0.6 | 16.6 | GO:0034101 | erythrocyte homeostasis(GO:0034101) |
0.6 | 6.1 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.6 | 1.1 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
0.6 | 5.5 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.6 | 3.9 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.6 | 1.7 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.6 | 2.8 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 1.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.6 | 0.6 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.5 | 0.5 | GO:1904356 | regulation of telomere maintenance via telomere lengthening(GO:1904356) |
0.5 | 1.6 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.5 | 2.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.5 | 1.1 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.5 | 1.6 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.5 | 0.5 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.5 | 1.6 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.5 | 0.5 | GO:0003032 | detection of oxygen(GO:0003032) |
0.5 | 1.6 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) |
0.5 | 2.7 | GO:1904970 | brush border assembly(GO:1904970) |
0.5 | 1.6 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.5 | 0.5 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.5 | 1.6 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 1.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.5 | 3.7 | GO:0075522 | IRES-dependent viral translational initiation(GO:0075522) |
0.5 | 4.8 | GO:0072376 | protein activation cascade(GO:0072376) |
0.5 | 3.2 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.5 | 1.1 | GO:0046633 | alpha-beta T cell proliferation(GO:0046633) |
0.5 | 3.2 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.5 | 2.6 | GO:0042095 | interferon-gamma biosynthetic process(GO:0042095) |
0.5 | 3.2 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
0.5 | 0.5 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.5 | 2.1 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.5 | 2.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.5 | 5.8 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.5 | 2.6 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.5 | 3.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.5 | 0.5 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.5 | 0.5 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.5 | 0.5 | GO:0010869 | regulation of receptor biosynthetic process(GO:0010869) |
0.5 | 4.1 | GO:0030149 | sphingolipid catabolic process(GO:0030149) |
0.5 | 1.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.5 | 2.1 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.5 | 1.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.5 | 1.0 | GO:1903867 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.5 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.5 | 3.6 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
0.5 | 0.5 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
0.5 | 20.3 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.5 | 1.5 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.5 | 1.5 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
0.5 | 1.0 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.5 | 1.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.5 | 1.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.5 | 2.0 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.5 | 6.5 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.5 | 2.5 | GO:0045123 | cellular extravasation(GO:0045123) |
0.5 | 0.5 | GO:0045730 | respiratory burst(GO:0045730) |
0.5 | 0.5 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.5 | 0.5 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.5 | 2.5 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.5 | 4.0 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.5 | 2.0 | GO:0051697 | protein delipidation(GO:0051697) |
0.5 | 7.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.5 | 1.5 | GO:0032570 | response to progesterone(GO:0032570) |
0.5 | 2.5 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.5 | 1.5 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.5 | 1.0 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.5 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.5 | 13.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.5 | 4.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.5 | 1.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.5 | 0.5 | GO:0071402 | cellular response to lipoprotein particle stimulus(GO:0071402) |
0.5 | 3.9 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.5 | 2.4 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.5 | 1.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.5 | 1.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
0.5 | 1.5 | GO:0090207 | regulation of triglyceride metabolic process(GO:0090207) |
0.5 | 1.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.5 | 1.5 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.5 | 1.9 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.5 | 1.0 | GO:0014856 | skeletal muscle cell proliferation(GO:0014856) |
0.5 | 6.3 | GO:0051180 | vitamin transport(GO:0051180) |
0.5 | 1.0 | GO:0031063 | regulation of histone deacetylation(GO:0031063) |
0.5 | 1.0 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.5 | 1.0 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.5 | 0.5 | GO:0060416 | response to growth hormone(GO:0060416) |
0.5 | 2.9 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.5 | 13.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.5 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.5 | 7.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.5 | 9.9 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.5 | 0.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.5 | 0.9 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.5 | 1.4 | GO:0002930 | trabecular meshwork development(GO:0002930) |
0.5 | 0.9 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.5 | 0.5 | GO:0070431 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway(GO:0035872) nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.5 | 3.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.5 | 5.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 3.7 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.5 | 1.4 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.5 | 2.8 | GO:0097286 | iron ion import(GO:0097286) |
0.5 | 0.5 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.5 | 2.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.5 | 0.5 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.5 | 0.9 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
0.5 | 0.5 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.5 | 8.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.5 | 0.9 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.5 | 1.8 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.5 | 2.3 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.5 | 4.1 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.5 | 1.8 | GO:0002839 | positive regulation of response to tumor cell(GO:0002836) positive regulation of immune response to tumor cell(GO:0002839) |
0.5 | 8.3 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.5 | 0.5 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 0.5 | GO:1901978 | positive regulation of cell cycle checkpoint(GO:1901978) |
0.5 | 8.2 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 0.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.5 | 4.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.5 | 1.4 | GO:0002159 | desmosome assembly(GO:0002159) |
0.5 | 6.8 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.5 | 1.4 | GO:0043633 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) |
0.5 | 3.6 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.5 | 1.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.5 | 8.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.4 | 3.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
0.4 | 1.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 1.3 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.4 | 1.8 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.4 | 2.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.4 | 5.4 | GO:0070303 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.4 | 0.4 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 0.9 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.4 | 0.9 | GO:1990748 | cellular detoxification(GO:1990748) |
0.4 | 0.4 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.4 | 1.8 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.4 | 1.3 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.4 | 4.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.4 | 2.6 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.4 | 0.4 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.4 | 5.7 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.4 | 0.4 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) |
0.4 | 10.1 | GO:0006284 | base-excision repair(GO:0006284) |
0.4 | 2.6 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.4 | 5.2 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.4 | 0.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 13.1 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.4 | 0.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.4 | 3.0 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.4 | 0.4 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 0.4 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.4 | 0.9 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.4 | 0.8 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 5.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.4 | 0.8 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.4 | 1.7 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.4 | 2.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.4 | 3.3 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.4 | 1.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.4 | 0.4 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.4 | 2.9 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.4 | 3.3 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.4 | 0.4 | GO:1903573 | negative regulation of response to endoplasmic reticulum stress(GO:1903573) |
0.4 | 0.8 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.4 | 2.1 | GO:0048535 | lymph node development(GO:0048535) |
0.4 | 1.2 | GO:0006971 | hypotonic response(GO:0006971) |
0.4 | 3.3 | GO:1901984 | negative regulation of protein acetylation(GO:1901984) |
0.4 | 2.9 | GO:0009299 | mRNA transcription(GO:0009299) |
0.4 | 7.4 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.4 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.4 | 2.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.4 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.4 | 1.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 | 1.6 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.4 | 6.1 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.4 | 2.0 | GO:0000237 | leptotene(GO:0000237) |
0.4 | 2.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.4 | 2.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 0.4 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.4 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.4 | 1.2 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 0.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.4 | 1.2 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.4 | 2.0 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.4 | 2.8 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.4 | 0.4 | GO:2001140 | regulation of phospholipid transport(GO:2001138) positive regulation of phospholipid transport(GO:2001140) |
0.4 | 13.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 2.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.4 | 3.1 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.4 | 14.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.4 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 1.5 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.4 | 1.2 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.4 | 1.5 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.4 | 1.2 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.4 | 0.8 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.4 | 1.2 | GO:0002215 | defense response to nematode(GO:0002215) |
0.4 | 0.4 | GO:0072217 | negative regulation of metanephros development(GO:0072217) |
0.4 | 2.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.4 | 6.5 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.4 | 4.6 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.4 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.4 | 0.4 | GO:0048290 | isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) |
0.4 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 0.4 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
0.4 | 1.5 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
0.4 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.4 | 0.4 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.4 | 0.4 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.4 | 5.3 | GO:0000154 | rRNA modification(GO:0000154) |
0.4 | 0.8 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.4 | 1.5 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.4 | 1.1 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 4.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.4 | 1.1 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.4 | 1.1 | GO:0036233 | glycine import(GO:0036233) |
0.4 | 1.1 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 0.4 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.4 | 1.5 | GO:1901976 | regulation of cell cycle checkpoint(GO:1901976) |
0.4 | 0.7 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
0.4 | 1.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.4 | 0.4 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.4 | 0.4 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.4 | 0.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.4 | 3.2 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.4 | 0.7 | GO:0000710 | meiotic mismatch repair(GO:0000710) |
0.4 | 0.4 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.4 | 2.1 | GO:0034405 | response to fluid shear stress(GO:0034405) |
0.4 | 0.4 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.4 | 0.4 | GO:0003164 | His-Purkinje system development(GO:0003164) |
0.4 | 0.7 | GO:0051023 | regulation of immunoglobulin secretion(GO:0051023) |
0.4 | 0.7 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.4 | 1.8 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.4 | 0.4 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.4 | 0.7 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 2.5 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.3 | 1.7 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.3 | 4.5 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.3 | 2.4 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.3 | 0.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.3 | 2.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.3 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.3 | 0.3 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 2.1 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.3 | 1.0 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.3 | 0.3 | GO:0009624 | response to nematode(GO:0009624) |
0.3 | 1.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.3 | 0.3 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
0.3 | 5.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.3 | 0.3 | GO:0010985 | negative regulation of lipoprotein particle clearance(GO:0010985) |
0.3 | 0.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.3 | 0.3 | GO:0006216 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 1.7 | GO:1901550 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
0.3 | 1.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.3 | 9.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.3 | 0.7 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 1.7 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.3 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.3 | 1.3 | GO:0015870 | acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
0.3 | 0.7 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.3 | 1.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.3 | 1.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.3 | 0.7 | GO:0046365 | monosaccharide catabolic process(GO:0046365) |
0.3 | 4.0 | GO:0015858 | nucleoside transport(GO:0015858) |
0.3 | 4.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.3 | 1.6 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.3 | 1.0 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 21.5 | GO:0007599 | hemostasis(GO:0007599) |
0.3 | 2.3 | GO:0070633 | transepithelial transport(GO:0070633) |
0.3 | 2.9 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.3 | 2.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.3 | 1.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
0.3 | 0.3 | GO:0070203 | regulation of establishment of protein localization to chromosome(GO:0070202) regulation of establishment of protein localization to telomere(GO:0070203) |
0.3 | 1.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.3 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.3 | 1.0 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.3 | 1.9 | GO:0051383 | kinetochore organization(GO:0051383) |
0.3 | 0.3 | GO:0019042 | viral latency(GO:0019042) |
0.3 | 1.6 | GO:0032324 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 2.6 | GO:0033363 | secretory granule organization(GO:0033363) |
0.3 | 2.2 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.3 | 0.6 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.3 | 11.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.3 | 1.6 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.3 | 3.8 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.3 | 0.6 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 1.9 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.3 | 2.2 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 1.3 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 0.3 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.3 | 0.6 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 3.1 | GO:0030183 | B cell differentiation(GO:0030183) |
0.3 | 1.6 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.3 | 7.2 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
0.3 | 1.6 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.3 | 3.7 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.3 | 1.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.3 | 0.3 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.3 | 1.5 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.3 | 0.9 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
0.3 | 0.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.3 | 1.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.3 | 1.2 | GO:0034391 | smooth muscle cell apoptotic process(GO:0034390) regulation of smooth muscle cell apoptotic process(GO:0034391) |
0.3 | 0.9 | GO:0016045 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
0.3 | 0.6 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 1.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.3 | 2.1 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.3 | 0.9 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.3 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.3 | 0.3 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.3 | 4.5 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 0.9 | GO:0015817 | histidine transport(GO:0015817) |
0.3 | 0.6 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 2.4 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.3 | 0.6 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.3 | 1.5 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.3 | 0.6 | GO:0031446 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.3 | 0.3 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.3 | 0.3 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.3 | 0.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.3 | 12.2 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.3 | 0.3 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.3 | 1.4 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.3 | 3.7 | GO:0016180 | snRNA processing(GO:0016180) |
0.3 | 1.1 | GO:0030033 | microvillus assembly(GO:0030033) |
0.3 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.1 | GO:1904181 | positive regulation of membrane depolarization(GO:1904181) |
0.3 | 0.6 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.3 | 0.6 | GO:0051255 | spindle midzone assembly(GO:0051255) |
0.3 | 2.3 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.3 | 1.4 | GO:0046037 | GMP metabolic process(GO:0046037) |
0.3 | 0.3 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.3 | 1.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.3 | 0.3 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.3 | 0.8 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.3 | 0.3 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.3 | 0.3 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.3 | 3.9 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.3 | 1.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.3 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 5.5 | GO:0006414 | translational elongation(GO:0006414) |
0.3 | 0.8 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.3 | 3.8 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.3 | 0.3 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 0.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.3 | 0.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.3 | 0.3 | GO:1903598 | positive regulation of gap junction assembly(GO:1903598) |
0.3 | 0.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.3 | 1.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.3 | 2.7 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.3 | 1.1 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.3 | 0.8 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.3 | 0.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.3 | 0.8 | GO:0015671 | oxygen transport(GO:0015671) |
0.3 | 1.3 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.3 | 1.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.3 | 1.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.3 | 0.3 | GO:0061055 | myotome development(GO:0061055) |
0.3 | 12.0 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 1.6 | GO:0051168 | nuclear export(GO:0051168) |
0.3 | 2.1 | GO:0051923 | sulfation(GO:0051923) |
0.3 | 0.8 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.3 | 0.3 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.3 | 0.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.3 | 1.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 0.8 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.3 | 0.5 | GO:0032789 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.3 | 4.5 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.3 | 3.5 | GO:0006953 | acute-phase response(GO:0006953) |
0.3 | 0.3 | GO:0050942 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.2 | 2.2 | GO:0090224 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
0.2 | 1.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.2 | 0.2 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.2 | 1.2 | GO:0006968 | cellular defense response(GO:0006968) |
0.2 | 1.5 | GO:0003081 | regulation of systemic arterial blood pressure by renin-angiotensin(GO:0003081) |
0.2 | 0.7 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.2 | 1.2 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.2 | 0.7 | GO:0051693 | actin filament capping(GO:0051693) |
0.2 | 3.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.2 | 1.7 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.2 | 0.5 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.2 | 1.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.2 | 1.2 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
0.2 | 0.2 | GO:0072422 | signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
0.2 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 5.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.2 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 1.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.2 | 0.9 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 1.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 0.5 | GO:0048022 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 0.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 0.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.2 | 1.2 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.2 | 3.5 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.2 | 8.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.2 | 0.2 | GO:0032909 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.2 | 2.3 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.2 | 0.9 | GO:0050832 | defense response to fungus(GO:0050832) |
0.2 | 6.4 | GO:0006909 | phagocytosis(GO:0006909) |
0.2 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.2 | 0.2 | GO:0003162 | atrioventricular node development(GO:0003162) |
0.2 | 1.6 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.2 | 0.2 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 2.7 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.2 | 0.9 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.2 | 0.7 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.2 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.2 | 0.4 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.2 | 0.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.2 | 1.7 | GO:0002385 | organ or tissue specific immune response(GO:0002251) mucosal immune response(GO:0002385) |
0.2 | 0.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.2 | GO:0042737 | drug catabolic process(GO:0042737) |
0.2 | 0.4 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.6 | GO:0033344 | cholesterol efflux(GO:0033344) |
0.2 | 0.4 | GO:0019856 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
0.2 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.2 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 1.7 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.2 | GO:1901836 | regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901836) |
0.2 | 0.9 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 5.3 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.2 | 0.6 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 0.2 | GO:0010700 | negative regulation of norepinephrine secretion(GO:0010700) |
0.2 | 0.2 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 0.6 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
0.2 | 0.2 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.6 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 0.8 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.2 | 0.4 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
0.2 | 0.2 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.2 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 1.0 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.2 | 1.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 1.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.6 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.2 | 0.8 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.2 | 0.2 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
0.2 | 1.4 | GO:0071435 | potassium ion export(GO:0071435) |
0.2 | 1.0 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.2 | 1.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.2 | 0.4 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.2 | 0.2 | GO:0002461 | complement receptor mediated signaling pathway(GO:0002430) tolerance induction dependent upon immune response(GO:0002461) |
0.2 | 0.2 | GO:0010884 | positive regulation of lipid storage(GO:0010884) |
0.2 | 0.2 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.2 | 0.8 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 2.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 0.4 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.2 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.2 | 0.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.2 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.4 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.2 | 1.5 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.7 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 0.9 | GO:0016556 | mRNA modification(GO:0016556) |
0.2 | 0.2 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.2 | 0.4 | GO:0048340 | paraxial mesoderm morphogenesis(GO:0048340) |
0.2 | 3.6 | GO:0043627 | response to estrogen(GO:0043627) |
0.2 | 20.5 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 0.2 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.2 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.2 | 0.4 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
0.2 | 0.2 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.2 | 0.2 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.2 | 0.5 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 0.4 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 0.7 | GO:0034389 | lipid particle organization(GO:0034389) |
0.2 | 0.5 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.2 | 1.2 | GO:0017144 | drug metabolic process(GO:0017144) |
0.2 | 1.0 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
0.2 | 0.5 | GO:0033762 | response to glucagon(GO:0033762) |
0.2 | 0.3 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.2 | 0.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.2 | 0.5 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.2 | 0.5 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.2 | 0.9 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.2 | 0.2 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.2 | 0.3 | GO:0070268 | cornification(GO:0070268) |
0.2 | 0.2 | GO:0051409 | response to nitrosative stress(GO:0051409) cellular response to nitrosative stress(GO:0071500) |
0.2 | 0.2 | GO:0048865 | stem cell fate commitment(GO:0048865) |
0.2 | 0.5 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
0.2 | 0.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.2 | 0.5 | GO:0061615 | glycolytic process through fructose-6-phosphate(GO:0061615) |
0.2 | 0.2 | GO:0001774 | microglial cell activation(GO:0001774) |
0.2 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.2 | 0.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.2 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.2 | 1.1 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.2 | 0.6 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.2 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.2 | 0.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.2 | 0.9 | GO:0072676 | lymphocyte migration(GO:0072676) |
0.2 | 0.3 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.8 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.2 | 0.2 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.2 | 4.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.2 | 0.2 | GO:0019348 | polyprenol catabolic process(GO:0016095) dolichol metabolic process(GO:0019348) |
0.1 | 0.6 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.1 | 0.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 1.3 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.3 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.1 | 0.1 | GO:0007418 | ventral midline development(GO:0007418) floor plate morphogenesis(GO:0033505) |
0.1 | 0.1 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.1 | 0.6 | GO:0033273 | response to vitamin(GO:0033273) |
0.1 | 0.7 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.1 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
0.1 | 0.3 | GO:0048021 | regulation of melanin biosynthetic process(GO:0048021) regulation of secondary metabolite biosynthetic process(GO:1900376) |
0.1 | 0.1 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.1 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.4 | GO:0071398 | cellular response to fatty acid(GO:0071398) |
0.1 | 0.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 1.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 2.1 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.1 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.1 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.1 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.1 | 3.5 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.1 | 0.6 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 1.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 0.1 | GO:1901298 | regulation of hydrogen peroxide-mediated programmed cell death(GO:1901298) |
0.1 | 0.3 | GO:0051549 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 12.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.6 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.1 | 1.1 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
0.1 | 0.4 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 0.1 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.1 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 1.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 6.7 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.4 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.1 | 0.1 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.1 | 1.6 | GO:0045740 | positive regulation of DNA replication(GO:0045740) |
0.1 | 0.2 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.1 | 0.3 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.1 | 0.6 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.1 | 0.5 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.1 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.1 | 0.1 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 1.0 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.5 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.9 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.1 | 0.2 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 0.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.6 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 0.2 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 1.0 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.1 | 0.3 | GO:1903318 | negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
0.1 | 0.3 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.1 | 4.0 | GO:0006959 | humoral immune response(GO:0006959) |
0.1 | 1.3 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.3 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
0.1 | 1.3 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 0.1 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.1 | 0.3 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.1 | 0.5 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.1 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.1 | 0.3 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.1 | 0.1 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
0.1 | 0.1 | GO:0032252 | secretory granule localization(GO:0032252) |
0.1 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.1 | 0.2 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.1 | 0.3 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.1 | 3.3 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.1 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.1 | 0.4 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.1 | 0.5 | GO:0007602 | phototransduction(GO:0007602) |
0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.1 | 0.4 | GO:0015893 | drug transport(GO:0015893) |
0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.6 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 0.1 | GO:0009301 | snRNA transcription(GO:0009301) |
0.1 | 0.1 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.1 | 0.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.1 | 0.5 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 5.0 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.1 | 0.1 | GO:0002138 | retinoic acid biosynthetic process(GO:0002138) diterpenoid biosynthetic process(GO:0016102) |
0.1 | 1.1 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.1 | 0.7 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 1.2 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.2 | GO:0045620 | negative regulation of lymphocyte differentiation(GO:0045620) |
0.1 | 0.1 | GO:0042628 | mating plug formation(GO:0042628) single-organism reproductive behavior(GO:0044704) post-mating behavior(GO:0045297) |
0.1 | 0.1 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.1 | 0.1 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.1 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 0.1 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.4 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 1.7 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.1 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
0.1 | 0.1 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) |
0.1 | 0.4 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.3 | GO:1903019 | negative regulation of glycoprotein metabolic process(GO:1903019) |
0.1 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.1 | 0.3 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.1 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.1 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.7 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.1 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.1 | 0.1 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.1 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.1 | GO:0051452 | intracellular pH reduction(GO:0051452) |
0.1 | 0.8 | GO:0006997 | nucleus organization(GO:0006997) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 0.1 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.1 | 0.2 | GO:0009112 | nucleobase metabolic process(GO:0009112) |
0.1 | 0.3 | GO:1901409 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.1 | 0.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.1 | 0.2 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.1 | 1.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.1 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.1 | 0.5 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.1 | 0.2 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.1 | 0.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.1 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.1 | 0.1 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 0.1 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.0 | 0.3 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.0 | 0.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.0 | 0.2 | GO:0006893 | Golgi to plasma membrane transport(GO:0006893) |
0.0 | 0.2 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.0 | 0.0 | GO:0032607 | interferon-alpha production(GO:0032607) |
0.0 | 0.0 | GO:0045683 | negative regulation of epidermal cell differentiation(GO:0045605) negative regulation of epidermis development(GO:0045683) |
0.0 | 0.0 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 1.8 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.0 | 0.1 | GO:0072512 | ferric iron transport(GO:0015682) trivalent inorganic cation transport(GO:0072512) |
0.0 | 4.2 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.7 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.0 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
0.0 | 0.0 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.2 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.3 | GO:0000281 | mitotic cytokinesis(GO:0000281) |
0.0 | 0.0 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.0 | GO:0006063 | uronic acid metabolic process(GO:0006063) glucuronate metabolic process(GO:0019585) cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.5 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.0 | 0.0 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.0 | 0.1 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.0 | GO:2001201 | transforming growth factor-beta secretion(GO:0038044) regulation of transforming growth factor-beta secretion(GO:2001201) |
0.0 | 0.0 | GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway(GO:0010803) |
0.0 | 0.3 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
0.0 | 0.3 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0021557 | oculomotor nerve development(GO:0021557) |
0.0 | 0.0 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.0 | 0.1 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:1903998 | regulation of eating behavior(GO:1903998) |
0.0 | 0.0 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.1 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
0.0 | 0.0 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
0.0 | 0.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.0 | 0.0 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.0 | 0.0 | GO:0051194 | positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.0 | 0.1 | GO:0030857 | negative regulation of epithelial cell differentiation(GO:0030857) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.0 | 35.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
5.0 | 14.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
4.8 | 23.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.7 | 23.4 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
4.6 | 23.1 | GO:0005579 | membrane attack complex(GO:0005579) |
3.0 | 14.8 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.9 | 17.5 | GO:0031983 | vesicle lumen(GO:0031983) |
2.9 | 17.1 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.6 | 25.9 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
2.5 | 15.3 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
2.2 | 2.2 | GO:0070552 | BRISC complex(GO:0070552) |
2.2 | 6.6 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
2.1 | 4.2 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
2.1 | 6.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.0 | 9.9 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
2.0 | 11.8 | GO:0042629 | mast cell granule(GO:0042629) |
1.9 | 1.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.8 | 14.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
1.8 | 20.3 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.8 | 7.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
1.7 | 19.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.7 | 6.9 | GO:1990130 | Iml1 complex(GO:1990130) |
1.7 | 5.1 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.6 | 14.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.6 | 8.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.6 | 22.5 | GO:0031528 | microvillus membrane(GO:0031528) |
1.6 | 4.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.6 | 1.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
1.6 | 9.4 | GO:0097342 | ripoptosome(GO:0097342) |
1.6 | 6.2 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.5 | 10.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.5 | 4.6 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
1.5 | 10.7 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.5 | 7.3 | GO:0030056 | hemidesmosome(GO:0030056) |
1.5 | 5.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.5 | 5.8 | GO:0061689 | tricellular tight junction(GO:0061689) |
1.4 | 139.2 | GO:0072562 | blood microparticle(GO:0072562) |
1.4 | 5.6 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
1.4 | 19.3 | GO:0001891 | phagocytic cup(GO:0001891) |
1.3 | 33.1 | GO:0008305 | integrin complex(GO:0008305) |
1.3 | 7.9 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.3 | 6.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.2 | 3.7 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
1.2 | 5.0 | GO:1990246 | uniplex complex(GO:1990246) |
1.2 | 6.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.2 | 9.8 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.2 | 1.2 | GO:0098827 | endoplasmic reticulum subcompartment(GO:0098827) |
1.2 | 7.3 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.2 | 1.2 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.2 | 2.4 | GO:0042627 | chylomicron(GO:0042627) |
1.2 | 3.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
1.2 | 1.2 | GO:0032010 | phagolysosome(GO:0032010) |
1.2 | 9.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
1.1 | 3.4 | GO:1990423 | RZZ complex(GO:1990423) |
1.1 | 8.0 | GO:0042382 | paraspeckles(GO:0042382) |
1.1 | 11.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.1 | 3.3 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.1 | 5.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.1 | 17.1 | GO:0000145 | exocyst(GO:0000145) |
1.1 | 15.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
1.1 | 2.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
1.0 | 13.5 | GO:0042581 | specific granule(GO:0042581) |
1.0 | 40.4 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.0 | 4.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
1.0 | 6.2 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
1.0 | 1.0 | GO:0098576 | lumenal side of membrane(GO:0098576) |
1.0 | 3.0 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
1.0 | 3.0 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
1.0 | 7.0 | GO:0031931 | TORC1 complex(GO:0031931) |
1.0 | 7.0 | GO:0000788 | nuclear nucleosome(GO:0000788) |
1.0 | 5.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.0 | 1.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.0 | 4.9 | GO:0005638 | lamin filament(GO:0005638) |
1.0 | 8.9 | GO:0002102 | podosome(GO:0002102) |
1.0 | 3.9 | GO:0071141 | SMAD protein complex(GO:0071141) |
1.0 | 21.5 | GO:0034451 | centriolar satellite(GO:0034451) |
1.0 | 3.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
1.0 | 2.9 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
1.0 | 3.9 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
1.0 | 1.0 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.9 | 1.9 | GO:0030894 | replisome(GO:0030894) |
0.9 | 3.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.9 | 4.6 | GO:0000796 | condensin complex(GO:0000796) |
0.9 | 2.7 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.9 | 4.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.9 | 2.7 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.9 | 3.5 | GO:0000836 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.9 | 2.6 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.9 | 6.1 | GO:0005688 | U6 snRNP(GO:0005688) |
0.8 | 4.2 | GO:0097422 | tubular endosome(GO:0097422) |
0.8 | 5.0 | GO:1990462 | omegasome(GO:1990462) |
0.8 | 1.7 | GO:0031523 | Myb complex(GO:0031523) |
0.8 | 5.0 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.8 | 2.5 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.8 | 4.2 | GO:0043203 | axon hillock(GO:0043203) |
0.8 | 2.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.8 | 2.5 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.8 | 3.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.8 | 2.4 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.8 | 32.6 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.8 | 1.6 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.8 | 7.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.8 | 2.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.8 | 1.6 | GO:0000791 | euchromatin(GO:0000791) |
0.8 | 3.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.8 | 2.3 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.8 | 33.1 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
0.8 | 4.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.8 | 3.0 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.8 | 23.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 6.7 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.7 | 8.1 | GO:0042555 | MCM complex(GO:0042555) |
0.7 | 2.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.7 | 2.2 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.7 | 1.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.7 | 10.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.7 | 2.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.7 | 40.4 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.7 | 2.2 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.7 | 5.0 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.7 | 2.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.7 | 3.5 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.7 | 1.4 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.7 | 2.8 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.7 | 4.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.7 | 24.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.7 | 0.7 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.7 | 1.4 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.7 | 7.5 | GO:0032039 | integrator complex(GO:0032039) |
0.7 | 2.7 | GO:0035339 | SPOTS complex(GO:0035339) |
0.7 | 4.1 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 8.8 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.7 | 6.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.7 | 2.7 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.7 | 3.4 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.7 | 1.3 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.7 | 2.6 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.7 | 3.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.6 | 1.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.6 | 7.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.6 | 4.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.6 | 1.9 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.6 | 3.8 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.6 | 3.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.6 | 3.1 | GO:0043219 | lateral loop(GO:0043219) |
0.6 | 1.9 | GO:0005745 | m-AAA complex(GO:0005745) |
0.6 | 5.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.6 | 4.2 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.6 | 3.6 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.6 | 1.8 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.6 | 1.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 4.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.6 | 15.7 | GO:0015030 | Cajal body(GO:0015030) |
0.6 | 2.9 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.6 | 2.9 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.6 | 1.7 | GO:0097413 | Lewy body(GO:0097413) |
0.6 | 5.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 1.2 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.6 | 5.8 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.6 | 2.3 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.6 | 2.8 | GO:0000812 | Swr1 complex(GO:0000812) |
0.6 | 37.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.6 | 1.7 | GO:0035838 | growing cell tip(GO:0035838) |
0.6 | 5.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.6 | 0.6 | GO:0061574 | ASAP complex(GO:0061574) |
0.6 | 3.4 | GO:0031415 | NatA complex(GO:0031415) |
0.6 | 16.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.6 | 1.7 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.6 | 14.6 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 0.6 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 2.2 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.6 | 2.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 2.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.6 | 2.2 | GO:0042825 | TAP complex(GO:0042825) |
0.5 | 51.9 | GO:0000793 | condensed chromosome(GO:0000793) |
0.5 | 5.4 | GO:0031143 | pseudopodium(GO:0031143) |
0.5 | 0.5 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.5 | 3.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.5 | 5.8 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.5 | 1.0 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.5 | 1.0 | GO:0000805 | X chromosome(GO:0000805) |
0.5 | 12.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.5 | 21.1 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
0.5 | 0.5 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.5 | 2.0 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.5 | 2.0 | GO:0070938 | contractile ring(GO:0070938) |
0.5 | 3.0 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.5 | 25.9 | GO:0005811 | lipid particle(GO:0005811) |
0.5 | 1.0 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.5 | 1.5 | GO:0072687 | meiotic spindle(GO:0072687) |
0.5 | 1.9 | GO:0038201 | TOR complex(GO:0038201) |
0.5 | 9.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.5 | 29.6 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 4.1 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.5 | 0.9 | GO:0005869 | dynactin complex(GO:0005869) |
0.5 | 1.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.4 | 7.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 5.4 | GO:0001741 | XY body(GO:0001741) |
0.4 | 4.0 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.4 | 1.3 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.4 | 2.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 1.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 14.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 3.9 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.4 | 0.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.4 | 0.4 | GO:0044393 | microspike(GO:0044393) |
0.4 | 1.7 | GO:0072487 | MSL complex(GO:0072487) |
0.4 | 5.9 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.4 | 4.2 | GO:0005682 | U5 snRNP(GO:0005682) |
0.4 | 0.4 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.4 | 2.1 | GO:0030914 | STAGA complex(GO:0030914) |
0.4 | 0.8 | GO:0005914 | spot adherens junction(GO:0005914) |
0.4 | 10.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.4 | 2.4 | GO:0032994 | protein-lipid complex(GO:0032994) |
0.4 | 0.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.4 | 2.8 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.4 | 1.2 | GO:0097542 | ciliary tip(GO:0097542) |
0.4 | 5.9 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.4 | 2.4 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.4 | 115.4 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 16.5 | GO:0000502 | proteasome complex(GO:0000502) |
0.4 | 29.4 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 4.7 | GO:0000974 | Prp19 complex(GO:0000974) |
0.4 | 2.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 5.4 | GO:0071010 | prespliceosome(GO:0071010) |
0.4 | 4.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.4 | 6.9 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 5.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.4 | 1.1 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.4 | 3.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
0.4 | 29.4 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.4 | 0.7 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 0.7 | GO:0089701 | U2AF(GO:0089701) |
0.4 | 38.3 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.4 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.4 | 7.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.4 | 5.7 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.4 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.4 | 3.9 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.4 | 0.4 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.3 | 5.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.3 | 2.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.3 | 1.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.3 | 15.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.3 | 1.0 | GO:0042827 | platelet dense granule(GO:0042827) |
0.3 | 0.3 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.3 | 5.7 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.3 | 0.3 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.3 | 0.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.3 | 2.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.3 | 5.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.3 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 2.2 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.3 | 0.6 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.3 | 15.3 | GO:0042641 | actomyosin(GO:0042641) |
0.3 | 11.5 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.3 | 5.9 | GO:1990391 | DNA repair complex(GO:1990391) |
0.3 | 3.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.3 | 0.3 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.3 | 1.8 | GO:0034719 | SMN complex(GO:0032797) SMN-Sm protein complex(GO:0034719) |
0.3 | 3.1 | GO:0045120 | pronucleus(GO:0045120) |
0.3 | 2.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 1.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.3 | 6.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.3 | 2.3 | GO:0000124 | SAGA complex(GO:0000124) |
0.3 | 0.6 | GO:0030689 | Noc complex(GO:0030689) |
0.3 | 81.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.3 | 1.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.3 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 0.9 | GO:0071564 | npBAF complex(GO:0071564) |
0.3 | 1.7 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.3 | 34.1 | GO:0000139 | Golgi membrane(GO:0000139) |
0.3 | 8.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.3 | 0.8 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 2.2 | GO:0070652 | HAUS complex(GO:0070652) |
0.3 | 3.3 | GO:0044815 | DNA packaging complex(GO:0044815) |
0.3 | 37.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 1.6 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.3 | 1.6 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.3 | 3.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 0.8 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.3 | 20.0 | GO:0005938 | cell cortex(GO:0005938) |
0.3 | 1.6 | GO:0090543 | Flemming body(GO:0090543) |
0.3 | 1.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 1.6 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.3 | 2.3 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 3.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.3 | 0.3 | GO:0046930 | pore complex(GO:0046930) |
0.3 | 11.0 | GO:0005643 | nuclear pore(GO:0005643) |
0.3 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.2 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.2 | 3.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 2.0 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.2 | 5.1 | GO:0016592 | mediator complex(GO:0016592) |
0.2 | 13.0 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.2 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.2 | 1.4 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.2 | 0.7 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.2 | 65.5 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.2 | 260.6 | GO:0005654 | nucleoplasm(GO:0005654) |
0.2 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.2 | 1.6 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.2 | 14.7 | GO:0000228 | nuclear chromosome(GO:0000228) |
0.2 | 1.3 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 0.4 | GO:0005955 | calcineurin complex(GO:0005955) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 2.5 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.2 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.4 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 0.6 | GO:0097546 | ciliary base(GO:0097546) |
0.2 | 3.3 | GO:0031901 | early endosome membrane(GO:0031901) |
0.2 | 0.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.1 | GO:0045171 | intercellular bridge(GO:0045171) |
0.2 | 7.6 | GO:0005903 | brush border(GO:0005903) |
0.2 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 0.7 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.2 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.2 | 5.0 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 1.8 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 0.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 13.5 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 215.5 | GO:0070062 | extracellular exosome(GO:0070062) |
0.1 | 1.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 2.6 | GO:0030118 | clathrin coat(GO:0030118) |
0.1 | 0.5 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 2.2 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 6.0 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 0.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.1 | 8.2 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.1 | 0.7 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.1 | 0.1 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 1.7 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.7 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.2 | GO:0030312 | external encapsulating structure(GO:0030312) |
0.1 | 0.2 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 1.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 13.8 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 1.0 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 1.0 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.7 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 6.1 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.1 | 0.2 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 0.1 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 30.8 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.0 | 0.1 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.1 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 0.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.0 | 0.0 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 0.2 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 0.0 | GO:0030880 | RNA polymerase complex(GO:0030880) |
0.0 | 0.0 | GO:0044452 | nucleolar part(GO:0044452) |
0.0 | 0.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.0 | 0.0 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 1.2 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.0 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.4 | GO:0005681 | spliceosomal complex(GO:0005681) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.8 | 23.1 | GO:0015265 | urea channel activity(GO:0015265) |
5.4 | 21.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
4.7 | 14.1 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
4.5 | 18.0 | GO:0031720 | haptoglobin binding(GO:0031720) |
4.3 | 13.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
4.2 | 29.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
4.0 | 16.1 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
3.9 | 11.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
3.8 | 15.3 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
3.4 | 13.7 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
3.3 | 13.1 | GO:0019158 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.2 | 13.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
3.2 | 9.7 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.2 | 6.4 | GO:0038181 | bile acid receptor activity(GO:0038181) |
3.2 | 9.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
3.1 | 12.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
3.0 | 11.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
3.0 | 3.0 | GO:0050897 | cobalt ion binding(GO:0050897) |
2.9 | 8.6 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.8 | 8.5 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.8 | 8.5 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
2.8 | 8.5 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
2.8 | 13.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.8 | 16.5 | GO:0004064 | arylesterase activity(GO:0004064) |
2.7 | 2.7 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.7 | 8.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
2.7 | 8.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
2.6 | 2.6 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
2.5 | 17.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
2.5 | 10.1 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
2.5 | 7.5 | GO:0030620 | U2 snRNA binding(GO:0030620) |
2.5 | 17.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
2.5 | 9.9 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.5 | 7.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
2.5 | 14.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
2.3 | 9.2 | GO:0051425 | PTB domain binding(GO:0051425) |
2.3 | 6.9 | GO:0019770 | IgG receptor activity(GO:0019770) |
2.2 | 6.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
2.2 | 19.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.1 | 8.6 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
2.1 | 6.4 | GO:0019862 | IgA binding(GO:0019862) |
2.1 | 8.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
2.1 | 6.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
2.1 | 14.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
2.0 | 6.1 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
2.0 | 18.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
2.0 | 2.0 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
2.0 | 16.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
2.0 | 4.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
2.0 | 2.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
2.0 | 11.8 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
1.9 | 5.8 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
1.9 | 9.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
1.9 | 9.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.9 | 9.4 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.9 | 11.2 | GO:0004768 | stearoyl-CoA 9-desaturase activity(GO:0004768) |
1.8 | 7.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.8 | 5.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
1.8 | 10.8 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
1.8 | 10.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
1.8 | 8.9 | GO:0005499 | vitamin D binding(GO:0005499) |
1.8 | 1.8 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
1.8 | 33.3 | GO:0001848 | complement binding(GO:0001848) |
1.7 | 6.9 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.7 | 17.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.7 | 5.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.7 | 1.7 | GO:0019213 | deacetylase activity(GO:0019213) |
1.7 | 88.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.7 | 8.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
1.7 | 8.3 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.7 | 5.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.6 | 1.6 | GO:0008142 | oxysterol binding(GO:0008142) |
1.6 | 4.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
1.6 | 6.5 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
1.6 | 1.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
1.6 | 1.6 | GO:0045340 | mercury ion binding(GO:0045340) |
1.6 | 1.6 | GO:0033142 | progesterone receptor binding(GO:0033142) |
1.6 | 4.8 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.6 | 3.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
1.6 | 4.8 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.6 | 3.2 | GO:0035877 | death effector domain binding(GO:0035877) |
1.6 | 4.7 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
1.6 | 7.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
1.6 | 6.2 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
1.5 | 6.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.5 | 4.6 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.5 | 6.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
1.5 | 4.6 | GO:0030984 | kininogen binding(GO:0030984) |
1.5 | 4.5 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.5 | 4.5 | GO:0055100 | adiponectin binding(GO:0055100) |
1.5 | 7.5 | GO:0043559 | insulin binding(GO:0043559) |
1.5 | 32.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
1.5 | 11.9 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
1.5 | 5.9 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
1.5 | 13.2 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.4 | 8.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.4 | 8.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.4 | 5.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
1.4 | 5.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
1.4 | 5.7 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
1.4 | 12.8 | GO:0039706 | co-receptor binding(GO:0039706) |
1.4 | 5.7 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
1.4 | 26.8 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
1.4 | 4.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
1.4 | 7.0 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
1.4 | 6.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.4 | 9.6 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.4 | 17.8 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.3 | 4.0 | GO:0004793 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.3 | 5.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.3 | 1.3 | GO:0004622 | lysophospholipase activity(GO:0004622) |
1.3 | 7.9 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.3 | 11.9 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
1.3 | 5.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
1.3 | 3.9 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
1.3 | 6.5 | GO:0016936 | galactoside binding(GO:0016936) |
1.3 | 19.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
1.3 | 7.7 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.3 | 3.8 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
1.3 | 7.6 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
1.3 | 3.8 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.3 | 10.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
1.3 | 7.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.2 | 18.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
1.2 | 7.5 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
1.2 | 5.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
1.2 | 3.7 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
1.2 | 6.0 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.2 | 3.6 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
1.2 | 3.6 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.2 | 4.7 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
1.2 | 7.1 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.2 | 4.7 | GO:0015057 | thrombin receptor activity(GO:0015057) |
1.2 | 3.5 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
1.2 | 3.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
1.2 | 1.2 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.2 | 3.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
1.2 | 4.6 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.2 | 3.5 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
1.1 | 19.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.1 | 3.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.1 | 32.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.1 | 5.6 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.1 | 4.5 | GO:0015232 | heme transporter activity(GO:0015232) |
1.1 | 5.6 | GO:0035473 | lipase binding(GO:0035473) |
1.1 | 3.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.1 | 5.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
1.1 | 5.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
1.1 | 11.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
1.1 | 5.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
1.1 | 3.3 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
1.1 | 3.3 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.1 | 1.1 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.1 | 2.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.1 | 4.3 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.1 | 3.2 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.1 | 19.2 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
1.1 | 4.3 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
1.1 | 2.1 | GO:0048030 | disaccharide binding(GO:0048030) |
1.0 | 9.4 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.0 | 7.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.0 | 3.1 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
1.0 | 3.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.0 | 9.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.0 | 8.3 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.0 | 5.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.0 | 4.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.0 | 1.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
1.0 | 31.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
1.0 | 13.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.0 | 4.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.0 | 19.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
1.0 | 3.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.0 | 5.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
1.0 | 1.0 | GO:0004096 | catalase activity(GO:0004096) |
1.0 | 2.9 | GO:0008430 | selenium binding(GO:0008430) |
1.0 | 7.8 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
1.0 | 14.5 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.9 | 5.7 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.9 | 10.3 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.9 | 0.9 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.9 | 6.6 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.9 | 8.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.9 | 7.3 | GO:0034863 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.9 | 3.7 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.9 | 1.8 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.9 | 4.5 | GO:0070061 | fructose binding(GO:0070061) |
0.9 | 2.7 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.9 | 2.7 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.9 | 3.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.9 | 16.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.9 | 4.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.9 | 7.1 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.9 | 0.9 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.9 | 2.6 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 5.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.9 | 6.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.9 | 2.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 8.6 | GO:0019865 | immunoglobulin binding(GO:0019865) |
0.9 | 18.9 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.9 | 3.4 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.8 | 0.8 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.8 | 0.8 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.8 | 2.5 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.8 | 0.8 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.8 | 1.7 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.8 | 6.7 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.8 | 1.7 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.8 | 2.5 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.8 | 2.5 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.8 | 2.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.8 | 10.8 | GO:0019825 | oxygen binding(GO:0019825) |
0.8 | 7.4 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.8 | 4.1 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.8 | 4.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.8 | 6.5 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.8 | 4.1 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.8 | 16.3 | GO:0005537 | mannose binding(GO:0005537) |
0.8 | 1.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.8 | 0.8 | GO:0003896 | DNA primase activity(GO:0003896) |
0.8 | 3.2 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.8 | 8.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.8 | 4.0 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.8 | 2.4 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.8 | 7.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.8 | 4.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.8 | 2.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.8 | 3.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.8 | 1.6 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.8 | 10.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.8 | 2.3 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 6.9 | GO:0010181 | FMN binding(GO:0010181) |
0.8 | 2.3 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.8 | 1.5 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.8 | 0.8 | GO:0019956 | chemokine binding(GO:0019956) |
0.8 | 2.3 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.8 | 0.8 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.8 | 3.0 | GO:0034618 | arginine binding(GO:0034618) |
0.8 | 0.8 | GO:0001846 | opsonin binding(GO:0001846) |
0.8 | 2.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.8 | 1.5 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.7 | 2.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.7 | 4.5 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.7 | 4.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.7 | 3.0 | GO:0035671 | enone reductase activity(GO:0035671) |
0.7 | 2.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.7 | 5.1 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.7 | 2.2 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.7 | 10.8 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 2.9 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.7 | 7.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.7 | 3.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.7 | 5.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.7 | 2.9 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.7 | 4.9 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.7 | 2.1 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.7 | 1.4 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.7 | 4.2 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 1.4 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.7 | 9.0 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.7 | 3.4 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.7 | 4.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 2.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.7 | 2.0 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.7 | 13.5 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.7 | 1.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.7 | 15.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.7 | 3.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 4.6 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.7 | 5.3 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.7 | 2.6 | GO:0042731 | PH domain binding(GO:0042731) |
0.7 | 18.4 | GO:0015485 | cholesterol binding(GO:0015485) |
0.7 | 4.6 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.7 | 2.6 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.7 | 8.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.7 | 2.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 2.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.6 | 5.2 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.6 | 0.6 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 2.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.6 | 4.4 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.6 | 1.3 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.6 | 8.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.6 | 4.4 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 6.3 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.6 | 2.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.6 | 21.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.6 | 1.9 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.2 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.6 | 7.4 | GO:0005521 | lamin binding(GO:0005521) |
0.6 | 6.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.6 | 7.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 1.8 | GO:0032558 | adenyl deoxyribonucleotide binding(GO:0032558) |
0.6 | 2.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.6 | 6.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.6 | 12.7 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.6 | 6.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 13.8 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.6 | 0.6 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.6 | 3.0 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.6 | 9.5 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.6 | 7.7 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.6 | 1.8 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.6 | 1.2 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.6 | 3.5 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.6 | 2.3 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 1.8 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.6 | 3.5 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.6 | 4.1 | GO:0060229 | lipase activator activity(GO:0060229) |
0.6 | 1.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 2.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.6 | 13.3 | GO:0030507 | spectrin binding(GO:0030507) |
0.6 | 5.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.6 | 3.5 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.6 | 4.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.6 | 1.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.6 | 2.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.6 | 4.0 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.6 | 1.7 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 7.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.6 | 1.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.6 | 1.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 2.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.6 | 2.3 | GO:0034452 | dynactin binding(GO:0034452) |
0.6 | 16.3 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.6 | 1.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.6 | 1.7 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.6 | 3.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.6 | 1.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.6 | 2.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.6 | 6.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.6 | 5.6 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.6 | 4.4 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.5 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.5 | 4.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.5 | 15.7 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
0.5 | 3.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.5 | 2.7 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.5 | 22.7 | GO:0005507 | copper ion binding(GO:0005507) |
0.5 | 1.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.5 | 1.1 | GO:1990190 | peptide-serine-N-acetyltransferase activity(GO:1990189) peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.5 | 3.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 59.4 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.5 | 2.7 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.5 | 1.6 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.5 | 2.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 2.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.5 | 5.2 | GO:0016307 | phosphatidylinositol phosphate kinase activity(GO:0016307) |
0.5 | 7.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.5 | 4.7 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.5 | 3.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.5 | 0.5 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.5 | 1.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.5 | 2.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.5 | 1.5 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.5 | 2.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.5 | 2.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.5 | 1.0 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.5 | 2.5 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 2.0 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.5 | 3.0 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 2.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.5 | 16.6 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
0.5 | 10.3 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.5 | 33.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.5 | 6.3 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.5 | 26.1 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.5 | 11.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.5 | 5.3 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 0.5 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.5 | 14.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.5 | 1.9 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.5 | 1.4 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 2.3 | GO:0015288 | porin activity(GO:0015288) |
0.5 | 4.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.5 | 2.8 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.5 | 0.5 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 8.3 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.5 | 1.4 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.4 | 1.8 | GO:0034547 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
0.4 | 1.8 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 3.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.4 | 1.3 | GO:0015154 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.4 | 3.6 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.4 | 7.1 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 8.8 | GO:0045502 | dynein binding(GO:0045502) |
0.4 | 1.8 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.4 | 2.2 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.4 | 0.9 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.4 | 0.9 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.4 | 4.3 | GO:0008143 | poly(A) binding(GO:0008143) |
0.4 | 0.9 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.4 | 0.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 1.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.4 | 1.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.4 | 0.9 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.4 | 0.8 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.4 | 2.5 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.4 | 3.0 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 8.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.4 | 77.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 0.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.4 | 1.7 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.4 | 4.5 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.4 | 4.5 | GO:0019177 | thiamine-pyrophosphatase activity(GO:0004787) UDP-2,3-diacylglucosamine hydrolase activity(GO:0008758) dATP pyrophosphohydrolase activity(GO:0008828) dihydroneopterin monophosphate phosphatase activity(GO:0019176) dihydroneopterin triphosphate pyrophosphohydrolase activity(GO:0019177) dTTP diphosphatase activity(GO:0036218) phosphocholine hydrolase activity(GO:0044606) |
0.4 | 1.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.4 | 1.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.4 | 0.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.4 | 1.2 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.4 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.4 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.4 | 68.3 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.4 | 13.1 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.4 | 14.9 | GO:0016876 | ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.4 | 1.6 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 3.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.4 | 0.4 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.4 | 5.1 | GO:0101005 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.4 | 1.9 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.4 | 3.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.6 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 1.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.3 | GO:0005123 | death receptor binding(GO:0005123) |
0.4 | 8.8 | GO:0000049 | tRNA binding(GO:0000049) |
0.4 | 1.5 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 0.4 | GO:0008199 | ferric iron binding(GO:0008199) |
0.4 | 3.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.4 | 15.5 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.4 | 1.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.4 | 0.4 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.4 | 36.3 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.4 | 1.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.4 | 0.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.4 | 1.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.4 | 2.2 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.4 | 3.3 | GO:0005542 | folic acid binding(GO:0005542) |
0.4 | 8.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.4 | 3.3 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 2.2 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.4 | 5.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.4 | 4.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 5.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 7.2 | GO:0043531 | ADP binding(GO:0043531) |
0.4 | 2.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.4 | 0.4 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.4 | 1.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 3.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 0.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.4 | 1.4 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.4 | 2.8 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.4 | 0.4 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 0.7 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.3 | 1.4 | GO:0034061 | DNA polymerase activity(GO:0034061) |
0.3 | 3.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 5.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 5.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 1.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 2.8 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.3 | 5.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.3 | 3.4 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.3 | 1.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.3 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.3 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.3 | 7.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 1.7 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.3 | 3.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.3 | 0.7 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 17.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.3 | 1.0 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 8.7 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.3 | 8.7 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.3 | 1.0 | GO:0019002 | GMP binding(GO:0019002) |
0.3 | 0.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.3 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.3 | 0.3 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.3 | 0.9 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 16.2 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 0.9 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 1.2 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 1.2 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.3 | 0.9 | GO:2001070 | starch binding(GO:2001070) |
0.3 | 1.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.3 | 0.6 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.3 | 6.8 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.3 | 0.6 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.3 | 2.4 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.3 | 2.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.3 | 1.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.3 | 11.9 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.3 | 1.2 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.3 | 2.8 | GO:0034869 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.3 | 1.1 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 0.9 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.3 | 0.8 | GO:0004529 | exodeoxyribonuclease activity(GO:0004529) exodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016895) |
0.3 | 1.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.3 | 7.0 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.3 | 0.8 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 11.8 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 2.8 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.3 | 1.9 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.3 | 2.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 1.6 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.3 | 11.2 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.3 | 1.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.3 | 12.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.3 | 7.2 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.3 | 1.3 | GO:0016208 | AMP binding(GO:0016208) |
0.3 | 2.1 | GO:0003905 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.3 | 1.1 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 3.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 2.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.5 | GO:0043426 | MRF binding(GO:0043426) |
0.3 | 0.8 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 1.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 21.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.3 | 2.1 | GO:0044548 | S100 protein binding(GO:0044548) |
0.3 | 0.3 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.3 | 0.5 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.3 | 4.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.3 | 0.3 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.3 | 8.3 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.3 | 6.5 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 1.0 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.2 | 2.2 | GO:0048029 | monosaccharide binding(GO:0048029) |
0.2 | 1.5 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.2 | 4.7 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.2 | 33.7 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.2 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.2 | 1.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.2 | 2.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.2 | 1.4 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 0.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.2 | 2.5 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.2 | 0.7 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
0.2 | 0.2 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.2 | 0.7 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 6.8 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.2 | 2.0 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.7 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.2 | 1.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.2 | 6.6 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.2 | 1.1 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.4 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.2 | 0.6 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.2 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 1.3 | GO:0031386 | protein tag(GO:0031386) |
0.2 | 0.9 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 3.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 1.1 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 2.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.2 | 0.4 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.2 | 0.4 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.2 | 1.2 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.2 | 1.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.2 | 0.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.2 | 0.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
0.2 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.8 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.2 | 0.8 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.2 | 2.4 | GO:0031491 | nucleosome binding(GO:0031491) |
0.2 | 0.2 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.2 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.2 | 1.0 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 0.2 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.2 | 1.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.2 | 4.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 0.4 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.2 | 1.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.2 | 0.9 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
0.2 | 25.6 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 0.6 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.2 | 7.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.2 | 0.2 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 1.4 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.9 | GO:1990405 | protein antigen binding(GO:1990405) |
0.2 | 3.3 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 1.2 | GO:0031996 | thioesterase binding(GO:0031996) |
0.2 | 0.2 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.2 | 0.3 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 0.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.2 | 1.0 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 4.6 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.2 | 1.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.2 | 0.3 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 4.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.2 | 0.9 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.2 | 2.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 5.5 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.1 | 0.9 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 1.7 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 5.6 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 2.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.1 | 1.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 3.2 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.1 | 3.2 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.4 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 1.6 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.1 | 0.5 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.1 | 0.5 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 1.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 4.4 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.3 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 1.8 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 1.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 3.0 | GO:0019707 | protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.5 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 3.2 | GO:0019209 | kinase activator activity(GO:0019209) |
0.1 | 0.1 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 3.1 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.1 | 0.1 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.1 | 0.9 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 3.6 | GO:0019842 | vitamin binding(GO:0019842) |
0.1 | 4.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 5.4 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 1.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.1 | 0.5 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 0.2 | GO:2001069 | glycogen binding(GO:2001069) |
0.1 | 1.8 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 4.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.1 | 10.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.1 | 0.5 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.1 | 0.1 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 0.2 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.1 | 0.2 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 2.4 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.2 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 1.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.5 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.1 | 0.5 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.9 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 1.7 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.1 | 0.6 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.6 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 4.5 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.5 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.5 | GO:0017069 | snRNA binding(GO:0017069) |
0.1 | 0.4 | GO:0034805 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.1 | 0.2 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 0.2 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.1 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.1 | 0.5 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.1 | GO:0015605 | organophosphate ester transmembrane transporter activity(GO:0015605) |
0.1 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.3 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.1 | 4.9 | GO:0051015 | actin filament binding(GO:0051015) |
0.1 | 0.3 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.1 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.4 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.1 | 1.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 0.1 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.1 | 2.8 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.7 | GO:0004518 | nuclease activity(GO:0004518) |
0.1 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.0 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.1 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.0 | 0.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.0 | 0.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.2 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.2 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 1.1 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
0.0 | 1.9 | GO:0042626 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.1 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.0 | 0.2 | GO:0050649 | testosterone 6-beta-hydroxylase activity(GO:0050649) |
0.0 | 0.1 | GO:0071949 | FAD binding(GO:0071949) |
0.0 | 0.1 | GO:0034584 | piRNA binding(GO:0034584) |
0.0 | 0.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.8 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.1 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.1 | GO:0034062 | RNA polymerase activity(GO:0034062) |
0.0 | 0.0 | GO:0035870 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) |
0.0 | 0.0 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.3 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 1.2 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.0 | 0.1 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.0 | 2.9 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.0 | 0.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 21.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 1.6 | GO:0070737 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.0 | 0.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.0 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 1.6 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.0 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.1 | GO:0061134 | peptidase regulator activity(GO:0061134) |
0.0 | 0.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 2.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
2.2 | 97.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
2.1 | 2.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
1.6 | 21.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.6 | 39.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
1.6 | 12.7 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.5 | 7.6 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.5 | 1.5 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
1.5 | 17.7 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.5 | 50.0 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.4 | 27.1 | PID EPO PATHWAY | EPO signaling pathway |
1.4 | 25.8 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
1.3 | 5.3 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
1.3 | 42.3 | PID ARF6 PATHWAY | Arf6 signaling events |
1.3 | 11.8 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
1.2 | 2.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
1.2 | 18.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.2 | 32.3 | PID BARD1 PATHWAY | BARD1 signaling events |
1.2 | 2.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.1 | 79.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.1 | 16.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.1 | 45.0 | PID ILK PATHWAY | Integrin-linked kinase signaling |
1.1 | 29.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.1 | 6.5 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
1.1 | 1.1 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
1.0 | 13.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.0 | 3.0 | ST STAT3 PATHWAY | STAT3 Pathway |
1.0 | 15.0 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.0 | 13.7 | PID BCR 5PATHWAY | BCR signaling pathway |
1.0 | 41.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.0 | 6.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.9 | 21.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.9 | 46.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.9 | 14.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.9 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.9 | 4.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.9 | 11.9 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.9 | 5.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.9 | 17.2 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.9 | 26.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.9 | 19.7 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.9 | 10.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.9 | 28.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.9 | 16.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.8 | 23.6 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.8 | 2.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.8 | 13.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.7 | 24.9 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.7 | 2.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.7 | 21.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.7 | 2.1 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.7 | 2.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.7 | 12.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.7 | 2.7 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.7 | 3.4 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.7 | 24.1 | PID P73PATHWAY | p73 transcription factor network |
0.6 | 6.3 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.6 | 5.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.6 | 2.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.6 | 3.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.6 | 13.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.6 | 1.2 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.6 | 3.5 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.6 | 5.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.6 | 17.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 14.1 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 5.9 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 2.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.5 | 5.8 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.5 | 5.1 | ST GAQ PATHWAY | G alpha q Pathway |
0.5 | 7.5 | PID ATR PATHWAY | ATR signaling pathway |
0.5 | 4.9 | PID ALK2 PATHWAY | ALK2 signaling events |
0.5 | 1.0 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.5 | 2.4 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.5 | 8.5 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.5 | 8.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 4.1 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 5.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.4 | 0.4 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.4 | 5.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.4 | 4.7 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.4 | 0.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 2.9 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.4 | 1.7 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.4 | 6.0 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.4 | 25.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.4 | 3.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.4 | 7.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.4 | 3.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.4 | 1.1 | PID IFNG PATHWAY | IFN-gamma pathway |
0.4 | 5.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.4 | 1.5 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.4 | 2.5 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 4.3 | PID ATM PATHWAY | ATM pathway |
0.4 | 6.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 3.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 1.7 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.3 | 10.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.3 | 2.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.3 | 12.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 59.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.3 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.3 | 7.2 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 1.7 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.2 | 3.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.2 | 0.4 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 0.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.2 | 1.8 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.2 | 3.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 1.9 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 2.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 1.6 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 2.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 4.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 2.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 1.0 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 0.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 1.9 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 0.6 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.2 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.6 | 64.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
2.9 | 29.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
2.7 | 32.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.3 | 29.3 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
1.9 | 16.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
1.8 | 20.3 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
1.8 | 17.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.8 | 28.0 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
1.7 | 29.4 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
1.7 | 28.8 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.6 | 37.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
1.6 | 14.4 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
1.6 | 22.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.6 | 16.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.6 | 1.6 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
1.6 | 1.6 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.4 | 33.3 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.4 | 41.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
1.4 | 10.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
1.3 | 40.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.3 | 25.2 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
1.3 | 7.8 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
1.3 | 20.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.3 | 16.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.3 | 11.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.2 | 6.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.2 | 18.2 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.2 | 9.5 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
1.2 | 12.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.2 | 27.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.1 | 16.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.1 | 4.4 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
1.1 | 30.7 | REACTOME G1 PHASE | Genes involved in G1 Phase |
1.1 | 36.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
1.1 | 20.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.1 | 3.2 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
1.1 | 2.1 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.0 | 14.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
1.0 | 99.0 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.0 | 11.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
1.0 | 10.2 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.0 | 5.0 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
1.0 | 9.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.0 | 3.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.0 | 4.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.0 | 1.9 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
1.0 | 22.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.9 | 9.4 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.9 | 11.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.9 | 28.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.9 | 1.8 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.9 | 6.4 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.9 | 27.1 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.9 | 6.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.9 | 9.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.9 | 0.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.9 | 5.2 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.9 | 5.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.9 | 8.5 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.8 | 8.5 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.8 | 22.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.8 | 11.7 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.8 | 14.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.8 | 38.7 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.8 | 1.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.8 | 2.4 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.8 | 17.8 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.8 | 8.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.8 | 1.6 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.8 | 2.4 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.8 | 1.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.8 | 7.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.8 | 4.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.8 | 24.5 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.8 | 6.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.8 | 6.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.8 | 15.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 33.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.8 | 3.0 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.8 | 11.3 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.7 | 15.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.7 | 58.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.7 | 0.7 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.7 | 26.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.7 | 10.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.7 | 2.8 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.7 | 2.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.7 | 2.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 6.9 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.7 | 2.7 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.7 | 8.9 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.7 | 14.9 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.7 | 44.6 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.7 | 1.3 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.7 | 6.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.7 | 9.2 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.7 | 0.7 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.7 | 15.6 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.6 | 9.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.6 | 8.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.6 | 10.1 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.6 | 8.7 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.6 | 12.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 17.0 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 8.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 9.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.6 | 1.8 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.6 | 3.4 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.6 | 2.3 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.6 | 5.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.6 | 10.6 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.5 | 7.6 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.5 | 15.6 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.5 | 5.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.5 | 5.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.5 | 11.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 27.2 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.5 | 1.0 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.5 | 2.6 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
0.5 | 6.6 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.5 | 8.6 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 0.5 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.5 | 0.5 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.5 | 4.4 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.5 | 1.4 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.5 | 12.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 3.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 2.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.5 | 3.3 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.5 | 6.0 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.4 | 1.3 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 4.9 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 7.0 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.4 | 0.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.4 | 3.0 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.4 | 5.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 10.2 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.4 | 63.9 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 4.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 3.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.4 | 1.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.4 | 2.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.4 | 33.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.4 | 1.2 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.4 | 1.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.4 | 4.1 | REACTOME TRANSLATION | Genes involved in Translation |
0.4 | 2.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.4 | 3.4 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.4 | 8.6 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.4 | 7.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 1.0 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.3 | 4.5 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 3.7 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.3 | 3.4 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.3 | 30.9 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 2.0 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 9.0 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.3 | 4.9 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.3 | 3.9 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.3 | 1.5 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.3 | 1.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.3 | 21.7 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 2.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.3 | 2.9 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.3 | 2.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 1.5 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.2 | 0.5 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.2 | 3.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.2 | 2.0 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.2 | 2.6 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 6.4 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 5.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.2 | 5.2 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 1.1 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 0.4 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 2.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.2 | 0.2 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 0.7 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.2 | 0.5 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.2 | 1.0 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.2 | 2.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.2 | 0.5 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.2 | 0.6 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.2 | 8.8 | REACTOME INNATE IMMUNE SYSTEM | Genes involved in Innate Immune System |
0.2 | 1.2 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.1 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
0.1 | 1.7 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 1.6 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.1 | 0.4 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.1 | 3.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.1 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 0.5 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.5 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.1 | 2.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 1.3 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.1 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 4.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.1 | 1.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 2.0 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.1 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 0.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.6 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.1 | 0.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 0.1 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.1 | 0.8 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.4 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.1 | 0.1 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.1 | 0.5 | REACTOME REGULATION OF APOPTOSIS | Genes involved in Regulation of Apoptosis |
0.1 | 1.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 2.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.3 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.0 | 0.1 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.0 | 0.4 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.1 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.0 | 2.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |